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Abstract  
 4 
Midbrain dopaminergic (mDA) neurons are involved in the regulation of 
movement and behavior, and their loss causes severe neurological disorders, such as 
Parkinson's disease. Foxa1 and Foxa2 (Foxa1/2), members of the Foxa family of 
forkhead/winged helix transcription factors, are expressed in mDA neurons throughout 
their development and display overlapping functions. Previously, it has been shown that 
Foxa1/2 regulate specification and differentiation of mDA neuron development. During 
specification, Foxa1/2 are required for the expression of Lmx1a, an intrinsic determinant 
of mDA identity. Recent data strongly suggests that Foxa2 cooperate with Lmx1a and 
Nurr1 (Nr4a2) in subsequent feed forward loops to regulate differentiation of mDA 
neurons. However, Foxa2 regulated direct targets and the mechanisms underlying its 
roles in mDA development are largely unknown. 
In this study, we performed chromatin immunoprecipitation (ChIP) and massively 
parallel Illumina 2G sequencing (ChIP-seq) using in vitro and in vivo DA systems. We 
produced a genome wide profile of Foxa2 binding sites at two stages of mDA neuron 
development: specification (in vitro), and differentiation (E12.5 and E14.5 in vivo tissue). 
Foxa2 binding was observed on known regulated elements, the Shh brain enhancer and 
the Foxa2 floor plate enhancer in both in vivo and in vitro data sets. Validation of 
candidate targets was carried out by independent in vivo ChIP-qPCR analysis and reverse 
transcriptase-qPCR expression assays using ventral midbrain tissue from both wild type 
and transgenic Foxa1;Foxa2 null mice. Furthermore, genomic regions in the Lmx1a and 
Lmx1b loci identified in our ChIP-seq analysis were validated for enhancer activity by 
transgenic LacZ reporter mice. These results strongly suggest that Foxa2 directly 
regulates the Lmx1a and Lmx1b enhancers emphasizing its key role in mDA 
 5 
specification. In addition, luciferase reporter assays in P19 cells demonstrate the 
combinatorial role of Foxa2 with Lmx1a and/or Nurr1 in regulating candidate enhancer 
regions of genes expressed in mDA neurons. These results confirm the quality of our data 
sets in predicting Foxa2 regulated target genes. 
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1. Introduction 
 
 
The mesencephalon is one of the most interesting regions of the central nervous 
system (CNS), and it provides a good model to study the mechanisms of how neural 
tissues are patterned and subdivided to generate distinct structures. Different neuronal 
populations within the mesencephalon have differing essential functions. The midbrain 
dopaminergic (mDA) neurons are members of this population that play important roles in 
movement control and behavior. These neurons are generated in specific spatial locations 
along both the anterior-posterior and dorsal-ventral axes in response to signals emanating 
from signaling centers positioned along the neural tube. In order to appreciate the 
mechanisms involved in the generation of mDA neurons, it is important to understand the 
events which are critical for the correct specification and patterning of the mesencephalon 
from the primitive neural tube. 
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1.1 Early neural tube patterning lead to create functionally diverse 
compartments  
 
Cells in the neural plate respond to multiple signals originating from primary 
signalling centres (organisers) and finally give rise to the central nervous system (CNS). 
The anterior visceral endoderm (AVE) plays an important role in anterior patterning and 
establishing the anterior limit of the developing embryo. Hensen’s node is another 
organizer that produces tissue which neurolizes the ectoderm and is important for 
maintaining and extending the anterior pattern in the mouse (Beddington and Robertson, 
1999; Stern, 2001; Wurst and Bally-Cuif, 2001). As a result of the signals from these 
organizers the neural plate roles up to form the neural tube and a series of vesicles 
develop in the anterior end of the neural tube indicating the position of the future 
prosencephalon or forebrain, mesencephalon or midbrain, and rhombencephalon or 
hindbrain (Wurst and Bally-Cuif, 2001). 
The prosencephalon undergoes a further subdivision to yield the telencephalon, which 
will give rise to the cerebral hemispheres, and the diencephalons, which will contain the 
thalamus and hypothalamus. The rhombencephalon also undergoes a further subdivision, 
yielding the metencephalon, which gives rise to the cerebellum and the pons, and the 
myelencephalon, which gives rise to the medulla (Figure 1-1). However, the 
mesencephalon does not undergo any further subdivision (Gilbert, 2003).  
After the closing of the neural tube and initial vesicular development of its anterior 
end, the three main domains in the brain premordium are subjected to further structural 
refinement by secondary signaling centres or secondary organizers. Secondary signaling 
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centers can be defined as focal transverse domains with morphogenetic activity across the 
anterior-posterior axis (Echevarría et al., 2003).   
 
 
Figure 1-1: Compartmentalisation of the neural tube. The anterior region of the neural tube forms 
specialised vesicles along the anterior-posterior axis and regions of the adult brain are derived from 
these vesicles (Adapted from Gilbert, 2003). 
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Three regions have been identified as secondary signaling centers in the anterior 
neural tube; the anterior neural ridge (ANR), the zona limitans intrathalamica (ZLI) and 
the isthmic organizer (IsO) (Echevarría et al., 2003; Kiecker and Lumsden, 2005).  
The ANR is a morphologically defined structure located at the junction between the 
most rostral part of the neural plate and non-neural ectoderm. It plays a crucial role in 
patterning the telencephalon (Echevarría et al., 2003). The ZLI is described as a 
compartment and source of local morphogenetic properties, which coincides with a 
surface constriction in the prospective thalamus, separating the dorsal from the ventral 
thalamus (Echevarría et al., 2003; Kiecker and Lumsden, 2004). The IsO, the best 
characterized organizer, is located at the boundary between the midbrain and anterior 
hindbrain (Bally-Cuif and Wassef, 1995). The IsO plays a critical role in inducing and 
polarizing midbrain and anterior hindbrain structures by emitting signals that have 
morphogenetic properties (Echevarría et al., 2003; Simeone, 2000; Wurst and Bally-Cuif, 
2001). The function of the IsO will be discussed in detail below. 
The main subdivisions of the CNS: the forebrain, midbrain, hindbrain and spinal 
cord, are established along the rostrocaudal axis of the neural tube. These events require 
an orchestration of signals emitted from multiple organizing centers within this signaling 
system. Another signaling system of similar complexity is the dorsoventral axis of the 
neural tube and it plays a critical role in establishing cell type diversity within these 
rostrocaudal subdivisions. Antagonistic interactions between ventralizing and dorsalizing 
signals ultimately lead to distinct regions of the neural tube known as the floor plate, the 
roof plate, the basal plate and the alar plate (Echelard Y, 1993; Jessell, 2000; Lee and 
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Jessell, 1999; Martí et al., 1995; Roelink et al., 1995). The floor plate will be discussed in 
detail later in this chapter. 
 
 
1.2  The IsO and its role in midbrain development 
 
The IsO has been identified in all studied vertebrates and is described as a local 
organizer of the embryonic brain. The IsO plays an important role in organizing the 
growth and the ordered rostrocaudal specification of the midbrain and hindbrain 
territories (Wurst and Bally-Cuif, 2001). The position of the IsO has been shown to 
depend on the expression of two homeodomain transcription factors Otx2 and Gbx2.  
Otx2 and Gbx2 are expressed by the headfold stage in the anterior and posterior 
neuroectoderm, respectively (Ang and Rossant, 1994). Genetic analysis of mutant mice 
lacking Otx2 demonstrates the absence of the anterior most regions of the neural tube, 
corresponding to the midbrain and forebrain regions (Acampora et al., 1995; Ang et al., 
1996). This is accompanied with the anterior expansion of Gbx2 expression and 
enlargement of the cerebellum. In contrast, mutant mice lacking Gbx2 protein results in 
the loss of the cerebellum at the expense of midbrain expansion. This is due to ectopic 
posterior expression of Otx2 (Liu and Joyner, 2001a; Martinez-Barbera et al., 2001). It 
has also been reported that Otx genes might cooperate and that a critical threshold of 
OTX proteins is required for regionalization and subsequent patterning of the developing 
brain. Also evidence has been provided that Otx gene dosage is required in controlling 
the boundary of the IsO (Acampora et al., 1997). Ectopic expression studies using either 
Otx2 or Gbx2 have produced similar results (Broccoli et al., 1999; Millet et al., 1999).  
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All these results clearly demonstrate that the IsO is positioned in the MHB 
between the expression domains of Otx2 and Gbx2, and that the correct position of the 
IsO is critical for determining the size of the mesencephalon and metencephalon. 
Recently it has been demonstrated that the establishment and specification of the IsO at 
the MHB is not dependent on the actions of either Otx2 or Gbx2, as genes such as Fgf8 
and Wnt1 normally expressed in a restricted manner at the MHB are still observed in 
Otx2/Gbx2 double mutants. However, they are essential for negatively regulating Fgf8 
and Wnt1, respectively, and thus subdividing the presumptive midhindbrain region into 
two different domains (Figure1-3) (Liu and Joyner, 2001a; Martinez-Barbera et al., 
2001).  
In recent years, studies have demonstrated the inducing capabilities of the IsO. 
Ectopically placing tissue from the MHB region into the host Forebrain can induce a new 
MHB region around the transplanted tissue (Liu and Joyner, 2001a; Nakamura H, 2005). 
Two classes of signaling molecules, Wnts and FGFs are expressed at the MHB. Wnt1 was 
originally identified as an oncogene due to frequent insertions of the mouse mammary 
tumour virus which lead to the over-expression of its transcript (Nusse and Varmus, 
1982), and is first expressed at the first somite stage and by the 6-8 somite stage is 
expressed throughout the presumptive midbrain (Echelard et al., 1994; Wilkinson DG). 
The expression of Wnt1 in the midbrain gradually becomes restricted to the ventral and 
dorsal midlines and to a small semi-circular domain at the posterior limit of the Otx2 
domain (Zervas et al., 2004). Fgf8 is first expressed during gastrulation and is eventually 
restricted to several signaling centers along the anterior-posterior axis (Crossley and 
Martin, 1995). The expression of Fgf8 within the MHB region is restricted posteriorally 
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to the expression of Wnt1, and forms a semi-circular domain of expression around the 
MHB (Crossley and Martin, 1995; Meyers et al., 1998).  
The MHB region is lost in Wnt1 knockout (Wnt1 -/-) embryos demonstrating the 
importance of this signaling molecule (McMahon AP, 1990; McMahon AP, 1992), but 
further studies have shown that Wnt1 is only required for the proliferation and survival of 
these cells (Danielian and McMahon, 1996; McMahon AP, 1992). Furthermore, Wnt1 
does not illustrate the inducing properties of the IsO as demonstrated in gain of function 
studies ( Danielian and McMahon, 1996). 
Fgf8 was demonstrated to posses the inducing capabilities of the IsO. Fgf8-soaked 
beads can transform the anterior forebrain into a MHB region (Crossley et al., 1996; Liu 
et al., 1999; Martinez et al., 1999). The requirement for Fgf8 during the development of 
the MHB was also demonstrated by using Fgf8 conditional knockout mice, as classical 
knockout mice have gastrulation defects (Sun et al., 1999). The loss of Fgf8 from the 
MHB results in the loss of the midbrain and anterior hindbrain (Chi et al., 2003). 
Furthermore, another role for FGF signaling from the IsO has been described in 
zebrafish. Fgf8 signals acting together with the Engrailed genes are important in the 
maintenance of the boundary between the midbrain and hindbrain (Scholpp S, 2003). 
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Signaling molecules from the IsO interact with signals from the floor plate to 
further refine, pattern and specify distinct neuronal populations along its neuraxis. For the 
purpose of this thesis, mechanisms for the specification of midbrain dopaminergic 
neurons will be discussed in following chapters. 
. 
 
 
 
 
 
 
 
Figure 1-2:The molecular code defining the midbrain hindbrain boundary 
(MHB).  
At E10.5the Otx2, Wnt1, Gbx2, Fgf8 and En1 domains of expression define a 
molecular code centered on the MHB. (Modified from Simeone,, 2000) 
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1.3  The Floor plate  
 
The specification of functionally diverse neuronal populations in the CNS depends 
on signaling molecules along the anterior-posterior and dorso-ventral axes. As discussed 
earlier in this chapter, signals coming from signaling centers are responsible for cell type 
specification along the dorso-ventral axis as it is for the anterior-posterior axis. The two 
signaling centers playing a central role in cell type specification along the dorso-ventral 
axis are the roof plate (dorsally) and the floor plate (ventrally). And the interaction of 
these dorsal and ventral signals are responsible for the specification of neurons along this 
axis (Jessell, 2000). 
The floor plate is described as a small group of cells located at the ventral midline of 
the neural tube that influences strongly the development of the vertebrate nervous system 
(Placzek and Briscoe, 2005). The floor plate was originally identified by its morphology 
by W. His, and was described as a group of cells in the ventral midline with an ependimal 
structure and lack of any differentiated neurons (Kingsbury, 1930). The floor plate cells 
participate in governing the specification of glial and neuronal cell types through 
secreting a key signalling molecule Shh (Briscoe and Ericson, 1999; Kessaris et al., 2001; 
Martí et al., 1995; Patten and Placzek, 2000; Placzek and Briscoe, 2005).  
Shh is first expressed in the midline mesoderm of the head at the late streak stages of 
gastrulation, and then extends to the notochord (Echelard et al., 1993). Shh expression 
initiates in the CNS at the ventral midline of the midbrain at 8-somite stage, and extends 
rostrally into the forebrain and caudally into the hindbrain and spinal cord. In the 
hindbrain and spinal cord, Shh expression is restricted to the FP, whereas it extends 
ventrolaterally in the midbrain (Echelard et al., 1993). Gain and loss of function data 
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have demonstrated the requirement of Shh to induce floor plate cells. It has been shown 
in studies where cells transfected with Shh expression vector and placed in close 
proximity with explants from naïve neural plate tissue are able to induce the 
differentiation of floor plate cells and motor neurons (Roelink et al., 1994). This has been 
supported by loss of function data where Shh -/- mice display a complete loss of floor 
plate structures (Chiang C. et al., 1996). It has also been demonstrated that Shh is the 
inductive signal derived from the FP that is responsible for the induction of midbrain 
dopaminergic (DA) and motor neurons (Hynes M. et al., 1995a).  
The Forkhead transcription factor Foxa2 has been shown to be one of the target 
genes of Shh signaling which plays a role as a major regulator of floor plate development 
(Sasaki and Hogan, 1994a; Sasaki et al., 1997; Sasaki et al.). Ectopic expression of Foxa2 
is sufficient to induce ectopic expression of Shh leading to the generation of ectopic floor 
plate structures (Sasaki and Hogan, 1994a). Moreover, Foxa2 loss of function results in 
loss of floor plate due to loss of Shh expression in the notochord (Ang and Rossant, 1994; 
Weinstein et al., 1994). 
 The floor plate has long been thought of as an organizer and involved in 
patterning nearby cells to their destined fates. The floor plate was not known to 
contribute to a specific neuronal population. Recently it was shown that in the midbrain 
this was not the case. Lineage tracing of mDA neurons using Shh-Cre driving the LacZ 
gene has shown that all the mDA neurons are generated from floor plate cells 
(Joksimovic et al., 2009). Moreover, cell sorting experiments coupled with 
immunostainig for DA specific markers using the membrane floor plate marker Corin has 
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further confirmed this finding (Ono et al., 2007). Thus in the ventral midbrain, the floor 
contributes to the mDA population in parallel to performing its patterning functions. 
1.4 The midbrain DA neurons 
 
1.4.1 Dopamine 
Dopamine (DA) belongs to the family of catecholamines (CA), which include 
noradrenalin and adrenaline. It is regarded as one of the classical neurotransmitters of the 
central nervous system. Dopamine, noradrenalin and adrenalin are synthesized from the 
amino acid tyrosine, and the first and rate-limiting step of this biosynthesis is catalyzed 
by the enzyme tyrosine hydroxylase (TH). TH converts tyrosine into L-
dihydroxyphenylalanine (L-DOPA) (Eells, 2003; Levitt et al., 1965; Nagatsu et al.). The 
enzyme L-aromatic amino acid decarboxykase (AADC or Ddc) catalyzes the 
decarboxylation of L-DOPA to form dopamine (Zhou and Palmiter, 1995). The enzymes 
dopamine β-hydroxylase (DBH) can further convert dopamine into noradrenalin by, and 
then to adrenalin by phenylethanolamine N-methyltransferase (Figure 1-3) (Goridis and 
Rohrer, 2002). DA neurons do not produce DBH; therefore, the CA synthesis terminates 
at DA. 
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1.4.2 The midbrain DA populations 
The DA neurons are one of the first systems to be described in detail. This was 
due to the ease of their detection by a histofluorescence method known as formaldehyde-
induced fluorescence (Falck et al., 1962; Goridis and Rohrer, 2002; Hokfelt et al., 1984; 
Zhou and Palmiter, 1995). Distinct subgroups of midbrain DA neurons can be identified 
according to cell body topology and axon connectivity with postsynaptic targets. 
Midbrain DA neurons are located in the substantia nigra (SN), ventral tegmentum (VTA) 
and retrorubral field (RRF), also known as subgroups A8-A10. It is interesting to note 
that the SN is divided into two sub groups: the pars compacta (SNc) and pars reticulata 
Figure 1-3: Biosynthesis of dopamine neurotransmitter. 
 Tyrosine Hydroxylase (TH) is the rate-limiting step of dopamine synthesis and is 
required to hydrolyse tyrosine and produce 
L
-DOPA. L-Aromatic Amino Acid 
Decaboxylase (AADC) then converts 
L
-DOPA into dopamine. (Diagram modified 
from Goridis and Rohrer, 2002) 
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(SNr). The SNc is composed of medium sized cells that are more darkly stained and 
closely spaced compared to the SNr. The SNc cells are mostly DA neurons whereas the 
SNr cells are mostly non-DA cells (Beckstead et al., 1979; Burbach et al., 2003; Goridis 
and Rohrer, 2002). In humans, approximately 75% of the midbrain DA neurons are 
located in the SN and project to the dorsal striatum forming the nigrostriatal pathways, 
which is involved in the control of voluntary motor movement (Figure 1-4) (Wallén and 
Perlmann, 2003; Zhou and Palmiter, 1995). DA neurons located in the VTA project to the 
nucleus acumbens, other limbic brain areas, and the cortex forming the 
mesolimbic/cortical pathways involved in the control of emotion and reward behaviors 
(Tzschentke, 2000; Tzschentke and Schmidt, 2000). 
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1.4.3 Midbrain DA neurons and Parkinson’s disease 
In 1817, James Parkinson first described the clinical manifestations of Parkinson’s 
disease (PD), of which the main symptoms are tremor, bradykinesia, and balance 
disturbances. Depression may also occur, but is less well defined. PD is a progressive 
Figure 1-4:The Nigrostriatal Pathway.  
A horizontal section of the adult rat brain stained with an antibody against tyrosine 
hydroxylase (TH). A dense bundle of fibres project rostro-laterally, beginning from 
the Substantia nigra compacta (SNc) towards the Striatum. VTA: Ventral tegmental 
area. RRF: Retrorubral field. (Kind contribution by Dr. Simon Stott). 
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neurodegenerative disorder that affects 1-2% of the population over 65 years of age. At 
the onset of the disease, a large proportion (70–80%) of DA neurons in the SNc has 
already been lost, resulting in reduced DA synthesis and release from the striatal nerve 
terminals (Hirsch et al., 1988; Jiang et al., 2005; Simon et al., 2003). DA neuron cell 
death is also associated with the presence of cytoplasmic protein aggregates called Lewi 
bodies (Goldman et al., 1983). It remains unclear what causes cell death of the SNc DA 
neurons. However, environmental toxins, ageing, and genetic susceptibility are key 
elements to consider for this disease (Eells, 2003; Hirsch, 1998; Jenner; 1998; Schapira, 
1997). 
The importance of genetic factors involved in Parkinson’s disease has been the 
centre of debate for decades, and an understanding of these genetic factors could hold the 
key to possible therapeutic treatments. Investigations with siblings from patients of 
Parkinson’s disease demonstrate that there is a higher possibility of developing 
Parkinsonian symptoms compared to the siblings of non-affected parents (Pankratz and 
Foroud, 2004), and several genes have now been identified which are considered to have 
the potential to increase the incidence of Parkinson’s disease, such as α-synuclein, parkin 
and DJ-1. 
1.4.4 The development of midbrain DA neurons (induction and molecular 
specification) 
As discussed earlier, the vertebrate nervous system is composed of multiple cell 
types that are organized at specific stereotypic locations along the anterior-posterior and 
dorso-ventral axis.  It has been shown that signaling centers along these axes such as the 
roof plate, floor plate and the IsO play crucial roles in instructing cell fates that will 
characterize the midbrain and hindbrain regions (Ye et al., 1998). A number of secreted 
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factors released from these signaling centers have been shown to modify cell fates along 
their axis of distribution, and this is in agreement with the notion that extracellular 
molecules establish information grids to instruct cell fate changes (Crossley et al., 1996; 
Kiecker and Lumsden; Ye et al., 1998). Such signals are Shh from the floor plate, BMP 
from the roof plate, Fgf8 and Wnt1 from the IsO region. These secreted molecules will be 
discussed in detail below. 
1.4.4.1 Induction of midbrain DA neurons by signaling molecules 
 
1.4.4.1.1 Shh 
Shh expression initiates in the CNS at the ventral midline of the midbrain at 8-
somite stage, and extends rostrally into the forebrain and caudally into the hindbrain and 
spinal cord. In the hindbrain and spinal cord, Shh expression is restricted to the FP, 
whereas it extends ventrolaterally in the midbrain (Echelard et al., 1993). In the 
developing midbrain, DA neurons were first suggested to develop in close proximity to 
the FP, which is also sufficient for the induction of DA neurons in midbrain explant 
cultures and in the dorsal midbrain with an ectopic FP (Hynes M. et al., 1995b). Shh is 
subsequently demonstrated to be the inductive signal derived from the FP that is 
responsible for the induction of DA neurons (Hynes M. et al., 1995a).  
 
 
1.4.4.1.2 Fgf8 
Fgf8 expression is detected in the prospective MHB between E8.0 and E8.5, and 
become restricted to the isthmic constriction at around E9.0 to E9.5 (Crossley and Martin, 
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1995). Fgf8 has been shown to mimic the inducing capabilities of the IsO by 
transforming the anterior forebrain when an Fgf8 source is placed close to it into a MHB 
region (Crossley et al., 1996; Liu et al., 1999; Martinez et al., 1999). Fgf8 signaling has 
been shown to directly regulate Wnt1 and En1/2 expression, which are also implicated in 
the development of midbrain DA neurons. This made it difficult to determine if Fgf8 
directly controls DA development (Crossley et al., 1996; Shamim et al., 1999). A recent 
study of mutant mice carrying different combinations of Fgfr1, Fgfr2, and Fgfr3 
mutations demonstrate redundant contributions of these receptors in receiving signals 
from the IsO and regulating the development of midbrain DA neurons without affecting 
the expression of Wnt1, Shh signaling and neurogenic gene expression in the ventral 
midbrain (Saarimäki-Vire et al., 2007). This suggests a more direct role of Fgf signaling 
in midbrain DA neuron development. 
 
1.4.4.1.3 Wnt1 
Wnt1 has been shown to regulate midbrain development by maintaining En1 
expression (Danielian and McMahon, 1996; McMahon AP, 1992; Wurst et al., 1994). In 
addition to the expression anterior to the isthmus, Wnt1 is also detected in two stripes 
adjacent to the floor plate of the midbrain and overlaps with the region where mDA 
progenitors first appear (Prakash et al., 2006). The function of Wnt1 in mDA neuron 
development has been shown by both in vitro and in vivo studies. Treatment of rat ventral 
midbrain cultures with Wnt1 conditioned media show that Wnt1 is a key regulator for the 
proliferation of mDA progenitors by exhibiting a dose depended increase in TH+ 
neurons. This effect is not specific to mDA progenitors but rather an effect on all ventral 
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midbrain progenitors (Castelo-Branco et al., 2003). The mechanism for this effect has 
been shown to be through the upregulation of cyclins D1 and D3, which promote cell 
cycle progression, and down-regulation of the expression of cell cycle inhibitors p27 and 
p57 (Prakash et al., 2006). Other than the role of Wnt1 in mDA precursor proliferation in 
vitro, it is also required for the proper differentiation of mDA neurons. In Wnt1-/- mutant 
embryos, only very few DA neurons were generated that expressed the mature mDA 
markers Nurr1 and TH, but these cells fail to express Pitx3 (Prakash et al., 2006) 
1.4.4.2 Molecular specification 
Midbrain DA neurons are known to have anatomical and functional differences. 
Despite these differences they share the dopamine biosynthesis and transmission 
machinery. The coordinated expressions of a cascade of transcription factors play key 
roles in these events (Burbach et al., 2003). A few of these transcription factors will be 
discussed here. 
1.4.4.2.1 The LIM-homeodomain transcription factors Lmx1a and Lmx1b 
Lmx1a and Lmx1b are LIM-homeodomain transcription factors. Lmx1a and 
Lmx1b are both expressed in the ventral midbrain and caudal forebrain where midbrain 
DA neurons are generated (Andersson et al., 2006b). Lmx1a transcript and protein are 
first detected in the ventral midbrain at E8.5 and E9 respectively (Andersson et al., 
2006b; Millen et al., 2004). Lmx1a is specifically expressed in midbrain DA progenitors 
and maintained in midbrain DA postmitotic neurons (Andersson et al., 2006b). Lmx1b is 
expressed broadly around the presumptive MHB at E8.5, and becomes restricted to the 
ventral midbrain and caudal forebrain at E9.5 (Guo et al., 2007). 
Lmx1b plays an early essential role in the development of the midbrain by 
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regulating the expression of Fgf8, Wnt1, En1 and Pax2 that are required for the midbrain 
and hindbrain development (Guo et al., 2007; Matsunaga et al., 2002). In the mDA 
system, Lmx1b is proposed to be required for the differentiation and maintenance of 
mDA neurons. The Lmx1b -/- mutant mice developed Th+ neurons that do not express 
the mature midbrain DA neuron marker Pitx3. These Th+ neurons are eventually lost 
during embryonic maturation. These results suggested the presence of two molecular 
cascades during the specification of midbrain DA neurons, one essential for the 
neurotransmitter phenotype and another essential for other midbrain DA neuron 
differentiation aspects (Smidt et al., 2000).  
Lmx1a is both required and sufficient to induce DA neurons in the ventral 
midbrain (Andersson et al., 2006a). Mis-expression of Lmx1a in chick midbrain at HH 
stage 10 extensively induces ectopic DA neurons in the ventral midbrain region, whereas 
siRNA knockdown of Lmx1a reduces postmitotic DA neurons. Lmx1a is both sufficient 
and required for the expression of Msx1 in midbrain DA progenitors. Lmx1a was shown 
to be a much more potent inducer of Th+ neurons than Lmx1b when transfected into 
mouse embryonic stem (mES) cells treated by Shh and Fgf8.  Furthermore a study using 
Lmx1a mouse mutant dreher has shown a significant reduction in midbrain DA neurons. 
These results illustrate the requirement of Lmx1a in midbrain DA neuron differentiation 
(Ono et al., 2007).  
1.4.4.2.2 The homeodomain transcription factors En1 & En2 
Engrailed 1 (En1) and Engrailed 2 (En2) are homeobox transcription factors with 
a high sequence homology (Joyner et al., 1985; Joyner and Martin, 1987). En1 and En2 
start to be expressed during the early hours of somite formation in the presumptive MHB 
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region (Davis and Joyner, 1988). En genes play an early role in maintaining the 
expression of Fgf8 in the MHB (Liu and Joyner, 2001b). 
In the mDA system, En1/2 are expressed in the mDA neurons during embryonic 
stages and the SN, and VTA at postnatal day 0 (P0). En1 is highly expressed by mostly 
all midbrain DA neurons in the SN and VTA, whereas En2 is expressed by a subset of 
them (Simon et al., 2001). In the development of mDA neurons, En1/2 substantially 
compensate for the loss of one another such that single mutants of either En1 or En2 
display a relatively normal appearance of SN and VTA. The double mutant analysis 
shows complete loss of SN and VTA DA neurons suggesting their strong requirement for 
midbrain DA neuron development. Moreover, the expression of α-synuclein, which has 
been genetically linked to PD in humans, is diminished at early stages of development in 
En 1 mutants and lost in En1/2 double mutants before the loss of the Th+ neurons (Simon 
et al., 2001). 
1.4.4.2.3 Msx1 
Msx1 (Muscle segment homeobox gene) is first expressed in mDA progenitors at 
E9.5, and remains restricted to a medial midbrain DA progenitors domain until E12.5 
(Andersson et al., 2006b). Although electroporation of Lmx1a into the chick ventral 
midbrain can induce Msx1 expression and DA fate, overexpression of Msx1 is 
insufficient to induce ectopic DA neurons in the midbrain (Andersson et al., 2006b). 
Similarly, transfection of Msx1 driven by the Nestin enhancer is insufficient to induce 
DA fate in mouse embryonic stem cells. Instead of mediating the induction of midbrain 
DA fate by Lmx1a, Msx1 functions to suppress alternative cell fate by repressing Nkx6.1, 
and to promote pan-neuronal differentiation. Therefore, it is suggested that Msx1 controls 
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the timing of DA cell neurogenesis. However, in Msx1 knockout embryos, there is only 
40% reduction in Ngn2+ progenitor cells and Nurr1+ DA neurons, suggesting that other 
factors, possibly Msx2, may compensate for the loss of Msx1 in DA neuron generation 
(Andersson et al., 2006b). 
1.4.4.2.4 Neurogenin 2 (Neurog2) 
The proneural gene Neurog2 is a BHLH transcription factor and is important for 
neuronal differentiation and neuronal subtype specification in various regions of the 
nervous system (Bertrand et al., 2002; Brunet and Ghysen, 1999; Guillemot, 1999). 
Neurog2 is expressed in midbrain DA progenitors but also in a few post mitotic Nurr1+ 
cells in the intermediate zone separating the progenitors from the Th+ mature neurons 
(Kele et al., 2006). 
Mutational studies in mouse show that Neurog2 is the major proneural gene involved 
in the development of midbrain DA neurons. The Neurog2 null mice have a substantial 
reduction of TH+ neurons at early stages of development, and only a few TH+ cells can 
be detected in the lateral edges of the DA domain. This phenotype gradually recovers 
later in development and is probably due to the compensation of other proneural genes 
such as Mash1 (Andersson et al., 2006b; Kele et al., 2006). Substituting Mash1 allele into 
the Ngn2 locus can only partially accelerate the development of midbrain DA neurons 
without providing a full recovery. This illustrates the unique requirement of Neurog2 for 
neurogenesis of the ventral midbrain DA neurons (Kele et al., 2006). 
1.4.4.2.5 Nurr1 
Nurr1 (Nr4a2) is a member of the nuclear hormone receptor family of ligand 
inducible transcription factors. It is known as an “orphan nuclear receptor” since its 
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ligand has not yet been identified. It is widely expressed in the CNS as well as in 
midbrain DA neurons at the time when they become postmitotic (Wallén et al., 1999). 
Mutant studies of the Nurr1 -/- mice show that these cells lose the expression of TH. 
They do maintain the expression of En1, AHD2, and Pitx3 during early development, but 
are lost at later stages. This illustrates that Nurr1 is not required for the initial 
specification step of midbrain DA neurons but is crucial for the maturation, migration and 
guidance of axons to their targets in the striatum. This is achieved by regulating the 
expression of mature mDA markers involved in these processes (Hermanson et al., 2003; 
Jacobs et al., 2009; Wallén et al., 1999). The identification of Nurr1 mutations in patients 
with familial PD has emphasized its clinical significance (Le et al., 2003). 
1.4.4.2.6 Pitx3 
The paired-like homeodomain transcription factor Pitx3 is expressed in the ventral 
midbrain from E11.5 onwards and its expression correlates with the appearance of 
midbrain DA neurons (Holland and Takahashi, 2005; Smidt et al., 1997). A knock-in 
GFP reporter of Pitx3 shows overlapping expression of GFP and TH in the vast majority 
of the mDA neurons in the SN and VTA (Zhao et al., 2004). On the contrary, a double 
immunohistochemistry study demonstrates the heterogeneity of Pitx3 expression in the 
midbrain DA populations (van den Munckhof et al., 2003). A study of naturally occurring 
Pitx3 mutant mice known as the aphakia mice suggests that Pitx3 functions in protecting 
DA neurons from cell death. Since the subpopulation expressing Pitx3 was more 
susceptible to cell death in these mutants (van den Munckhof et al., 2003). These results 
demonstrate the requirement of Pitx3 for the development and survival of at least a 
subpopulation of midbrain DA neurons. 
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1.4.4.2.7 The Forkhead box transcription factors Foxa1 and Foxa2 
In the CNS, Foxa1 and Foxa2 (previously know as HNF-3α and HNF-3β 
respectively) are expressed in the ventral midline of the neural tube, and it is spread more 
dorsally in the midbrain than in the posterior neural tube (Lai et al., 1990; Lai et al., 
1991; Sasaki and Hogan, 1993). The requirement of Foxa factors for the development of 
the ventral midbrain and more specifically DA neuron development will be discussed in 
following chapters. 
 
1.4.5 How to make a midbrain DA neuron in vitro 
 
Embryonic stem (ES) cells are clonal cell lines derived from the inner cell mass of 
the developing blastocyst that can proliferate extensively in vitro and are capable of 
adopting all the cell fates in a developing embryo (Evans et al., 1981). So far there have 
been two protocols developed specifically to differentiate ES cells towards a DA fate, one 
involves cell aggregation and the application of Shh and Fgf8 (Lee et al., 2000) and the 
other is via co-culture of ES cells with PA6 stromal cells (Kawasaki et al., 2000). The 
nature of stromal cell-derived inducing activity (SDIA) is unclear as PA6 neural inducing 
activity remains when the cells are fixed  (and unable to secrete soluble factors), or when 
the PA6 cells are separated from the ES cells. It is suggested that SDIA may be a secreted 
factor that is restrained to the cell surface, as treatment with heparin removes the neural 
inducing activity (Kawasaki et al., 2000). 
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 A serum-free adherent monolayer culture method has been developed in which ES 
cells can develop into neural precursors, and subsequently DA neurons can be produced 
upon addition of Fgf8 and Shh  (Ying et al., 2003).  Recently this method was used to 
differentiate ES cells that were first transfected with an expression vector containing the 
Lmx1a cDNA driven by the Nestin enhancer. The Nestin enhancer is only active when 
the ES cells acquire a neuronal progenitor fate. Since Lmx1a is a key player in the 
specification of the midbrain DA neuronal fate a large percentage of the transfected ES 
cells differentiated to midbrain DA neurons when compared to cells transfected with a 
control GFP construct driven by the Nestin enhancer (Figure 1-5) (Andersson et al., 
2006b). Midbrain DA neurons can now be efficiently produced in vitro to be used for 
further studies, especially for experiments that are difficult to execute using in vivo tissue. 
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Figure 1-5: TH expressing neurons derived from ES cells.  
NesE-Lmx1a genetically modified ES cells differentiated in serum 
free media upon the addition of Shh and Fgf8. The TH+ neurons 
from this assay also express Nurr1, DAT, Pitx3, and Lmx1a. 
(Modified From Anderson, 2006) 
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1.5 The Forkhead transcription factors 
 
1.5.1 History of the Forkhead genes 
 
In the 1990s, chromosomal walking was used to clone the Forkhead gene in 
Drosophila. The product of this gene did not posses a known, at the time, protein motif. 
Nor was its sequence similar at the time to any other known protein. Mutational analysis 
in Drosophila illustrated the importance of Forkhead for the development of terminal 
structures of the embryo that give rise to the anterior and posterior gut. The homeotic 
transformation of the gut structures into head structures created a two pronged mutant 
embryo, hence the name Forkhead (Weigel et al., 1989). 
Mammals also express Forkhead proteins and they were originally identified as 
proteins enriched in the rat liver and were given the name Hepatocyte nuclear factor 3 
(HNF-3). The first gene identified was HNF-3α (Lai et al., 1990). Following HNF-3α 
two other members of this transcription factor family were identified, HNF-3β, and HNF-
3γ (Liu et al., 1991). The DNA binding domain of the HNF-3 proteins is composed of 
∼110 amino acids and presents a high degree of conservation between the three members 
of this family (Figure 1-6) (Weigel and Jäckle, 1990). 
The solution of HNF-3γ three dimensional structure revealed a core of 3 α-helices 
and β-Sheets flanked by two large loops or “wings” and factors possessing this DNA 
binding domain were referred to as winged-helix transcription factors (Clark et al., 1993). 
 Now over 100 new members of this family have been identified and all the 
members of this family are referred to as Forkhead box transcription factors (Fox). 15 
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subclasses have been created depending on the similarities between each protein. The 
HNF-3 proteins have been allocated to subclass A with HNF-3α now called Foxa1, HNF-
3β is Foxa2, and HNF-3γ is Foxa3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-6: Schematic representation of functional domains present in Foxa1–3.  
Amino acid numbering is for the mouse proteins. All three family members share 95% 
identity within the forkhead domain, while outside this domain Foxa1 and Foxa2 are 39% 
identical and 51% similar. Outside of the forkhead domain, Foxa3 is only weakly similar 
to Foxa1 and Foxa2, with the greatest homology in the N-terminal and C-terminal 
transactivation domains. The C-terminal region has also been shown to interact with the 
core histones H3 and H4 (Cirillo et al., 2002). TA, transactivation domain; HI, histone 
interaction domain; NL, nuclear localization. (Modified from Friedmana and Kaestner, 
2006) 
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1.5.2 Control of Foxa2 expression within the floor plate 
 
Foxa2 is expressed in the notochord and in the ventral midline of the neural tube at 
embryonic days 8.5.(Ang and Rossant, 1994; Sasaki and Hogan, 1994a). The initial 
expression of Foxa2 within the ventral midline of the neural tube occurs within the 
presumptive mesencephalon. Foxa2 expression spreads more laterally in the midbrain 
when compared to the posterior neural tube (Ang and Rossant, 1994; Sasaki and Hogan, 
1994b). Foxa2 has been shown to be able to induce Floor plate, one of the main signaling 
centres involved in midbrain DA neuron development. The analysis was done by 
expresing Foxa2 under the control of the En1 prormoter. Floor plate markers such as 
Foxa1, and BMP1 were detected in the dorsal domain where Foxa2 is expressed 
suggesting that a Floor plate structure was generated ectopicaly (Sasaki and Hogan, 
1994b). Shh, an important morphogen for the correct specification of midbrain DA 
neurons, has been suggested to be induced by Foxa2 within the notochord and Floor 
plate(Echelard et al., 1993; Hynes et al., 1995). It was later determined that due to Shh 
signaling Foxa2 is induced by Gli1, a downstream target of Shh. This way Foxa2 and Shh 
expression is induced and maintained within the floor plate (Figure 1-7)(Hynes et al., 
1997; Sasaki et al., 1997). 
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Figure 1-7: Schematic of the notochord and floor plate showing the 
transcriptional cascade resulting in Shh expression. 
 In the notochord, Foxa2 activates Shh, which then signals to the 
overlying neural plate. In response to Shh signaling, Gli2 activates 
Foxa2 expression in the neural plate. Foxa2, in turn binds the Shh 
regulatory elements to stimulate Shh transcription in the floor plate. 
(Adapted from Jeong, et al 2003) 
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1.5.3 Role for Foxa2 in midbrain DA neuron development  
 
Recently it was shown that Foxa1 and Foxa2 are expressed in mDA progenitors and 
mature neurons  and their expression is maintained up to adulthood (Figure 1-8). This 
suggests that Foxa1 and Foxa2 may be required for the development and maintenace of 
mDA neurons (Ferri et al., 2007; Kittappa et al., 2007). Cre recombinase driven by the 
Nestin promoter of Foxa2 in the  mutant background of Foxa1 null mice deletes all Foxa 
proteins from the ventral midbrain region from E10.5 onwards. It is observed that mDA 
progenitors develop normaly and the region is properly specified since progenitor 
markers Lmx1a and Lmx1b can be detected in the progenitor domain at E10.5. In these 
mutants mDA neurons fail to mature properly since mature markers such as Th, Nurr1, 
and AADC are not detected. It is suggested that this is due to a block in neurogenesis 
since Neurog2 is misregulated in these mutants (Ferri et al., 2007). In a recent study 
where Cre recombinase was driven by the En1 promoter it was shown that Foxa factors 
are required for the expression of Lmx1a, the key specifier of midbrain DA neurons. This 
study also illustrated the requirement of Foxa factors for the correct specification of the 
mDA region by inhibiting the expression of the homeodomain transcription factor 
Nkx2.2(Lin et al., 2009). Chromatin Immunoprecipitation analysis suggests that Foxa2 
regulation of TH and Nkx2.2 gene expression is direct (Lin et al., 2009). More recently 
Foxa2 has been shown to synergise with other factors through a feed forward loop for the 
induction of the mDA phenotype (Ang, 2006 2010, Lee, 2010). It has been suggested that 
Lmx1a can only perform its downstream functions within a Foxa2 positive domain 
suggesting their cooporations for the proper differentiation of mDA neurons (Nakatani et 
al., 2010). Furthermore, Chromatin immunoprecipitation analysis of the TH promoter 
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demonstrates the requirement of Nurr1 for the efficient recruitment of Foxa2 to its 
binding site (Lee et al., 2010). 
 
 
 
 
 
Figure 1-8:Foxa2 expression during mouse ventral midbrain development.  
Coronal sections through E11.5 and adult mouse midbrain show (A-B) 
Expression of Foxa1 and Foxa2 (Red) is restricted to the ventral midbrain 
region were DA neurons are born at E11.5. (C-D) Foxa1 and Foxa2 
expression persists through adulthood as shown by ISH (E) Immunostaining 
of Foxa2 (Green) and TH (Red) indicates a high degree of overlap. (Figure 
‘E’ is a Kind contribution by Dr. Simon Stott). 
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Moreover, reduced levels of Foxa2 protein in the adult mouse mDA neurons leads to 
progressive loss of these neurons that is accompanied with motor behavioural defficit 
(Kittappa et al., 2007). These mutant mice provide a new model of Parkinson’s disease 
that exhibits both the late onset and patholgical characteristics. These studies show the 
importance of Foxa1 and Foxa2 for the generation and maitenance of mDA neurons. 
Further studies are required to clarify the mechanisms by which Foxa1 and Foxa2 
function to control the proper differentiation of mDA neurons. 
1.5.4 Foxa role in regulation of gene expression 
 
1.5.4.1 Nucleosome positioning and Chromatin opening 
The nucleosome (the basic unit of chromatin) consists of DNA wrapped nearly twice 
around an octamer of four core histone proteins. This structure is dynamic and open to 
transcriptional regulation (Felsenfeld, 1992). It is generally accepted that transcription is 
regulated by transcription factors, which modulate the recruitment of the basal 
transcriptional machinery to a nearby promoter (Ptashne and Gann, 1997). Nucleosomes 
positioned on promoters ensure that transcription will not occur spontaneously at the 
wrong time. This in turn requires transcriptional regulators to overcome this chromatin 
barrier and access their sites in order to affect transcription (Lomvardas and Thanos, 
2002). In the mouse liver, the N1, N2, and N3 nucleosomes are positioned over the serum 
albumin enhancer when active. The transcriptional machinery is bound on the 
nucleosomal DNA and not the linker DNA. Foxa binding sites have been identified in the 
N1 nucleosomal particle and have been shown to be required for the activity of this 
enhancer (Liu et al., 1991; Zaret, 1995). In 1993 Foxa transcription factors have been 
 55 
described to have a structure similar to linker histones, which have the capability to bind 
and compact chromatin. It was suggested that Foxa factors may possess similar 
nucleosomal binding capabilities (Clark et al., 1993). It was later revealed that Foxa 
proteins have the capability to position nucleosomes and this way organize the chromatin 
to a moor loose structure and allow further access to other transcription factors (Cirillo et 
al., 2002; Shim et al., 1998). 
 
1.5.4.2 Foxa function revealed by genome wide analysis of its recruitment to 
chromatin 
1.5.4.2.1 Chromatin immuno-precipitation 
Transcriptional regulation is a complex process that can be understood with the 
help of genome-wide mapping of protein-DNA interactions. A detailed map of binding 
sites for transcription factors and the core transcriptional machinery, which regulate 
various biological processes, can now be obtained and used to understand the regulatory 
networks involved in these processes (Park, 2009). Chromatin immuno-precipitation 
(ChIP) is the main tool used to investigate these mechanisms (Figure 1-9) (Solomon et 
al., 1988). In ChIP antibodies are used to select and enrich for a specific proteins that are 
bound to genomic DNA fragments. These DNA fragments can then be purified and used 
for down stream analysis. Quantitative PCR is the method used to obtain an accurate 
estimation of enrichment for predicted bound genomic regions, whereas the introduction 
of microarrays allowed the fragments from ChIP to be hybridized to a microarray chip 
(ChIP-chip). Therefore allowing the genome wide identification of DNA-protein 
interactions (Blat and Kleckner, 1999; Ren et al., 2000). 
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Recent advances in next generation sequencing (NGS) are now enabling the 
sequencing of hundreds of millions of short DNA fragments in a single run (Shendure 
and Ji, 2008). Chromatin immuno-precipitation followed by sequencing was one of the 
first applications of NGS (Barski et al., 2007; Robertson et al., 2007). Here the DNA 
fragments are sequenced directly instead of hybridizing them on an array. The higher 
resolution and greater coverage are just a few examples where ChIP-seq excels over 
ChIP-chip, thus providing substantially improved data. Te main disadvantage of ChIP-
seq is the cost and availability but these situations are being improved as well and we can 
expect ChIP-seq to become the method of choice in the near future for all ChIP 
experiments (Park, 2009). 
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Figure 1-9: An overview of the chromatin immuno-precipitation (ChIP) procedure. 
 Cells are initially cross-linked by 1% Formaldehyde agent that links DNA-interacting proteins to the 
DNA. The genomic DNA is then isolated and sheared by sonication, into a suitable fragment size 
distribution (100–300 bp used for ChIP- Seq). An antibody that specifically recognizes the protein of 
interest is then added and immuno-precipitation used to isolate appropriate protein–DNA complexes. 
The cross-links are then reversed and the DNA fragments purified (Modified from Hoffman and Jones, 
2009) 
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1.5.4.2.2 Chromosome wide analysis of Foxa1 targets in breast and prostate cancer 
models 
Foxa1 is commonly found highly expressed in tumors arising from prostate and 
estrogen receptor positive breast tumors (Lacroix and Leclercq, 2004). In a recent study 
curried out to identify Estrogen-regulated gene targets on a chromosome wide level 
identified Foxa proteins as cofactors required for the Estrogen mediated activity. Two 
families of nuclear receptors mediate the Estrogen regulation of gene expression, ERα, 
and ERβ. Chromatin immuno-precipitation of ER coupled with tiled arrays of 
Chromosomes 21-22 of breast cancer cells identified ER gene targets. Chromatin 
immuno-precipitation coupled with qPCR analysis of Foxa1 binding to the ER recruited 
regions identified ∼50% co-recruitment. Foxa1 was also shown to be required for the 
recruitment of ER to its targets (Carroll et al., 2005).  
Androgens are male hormones that play important roles in prostate development 
and development of other male sex organs and their function is mediated through nuclear 
receptors known as androgen receptors (AR). Foxa1 was shown to interact with AR in 
prostate cancer cells (Gao et al., 2003). In a later study where gene targets were identified 
for ER in breast cancer cells and for AR in prostate cancer cells, the authors show that 
Foxa1 differential activity in these breast and prostate cells relies on its differential 
recruitment to its target sites and its alternative collaboration with the lineage specific 
factors ER and AR at tissue specific enhancers. Foxa1 recruitment was also shown to 
correlate with histone modifications identified in transcriptionally active regions in these 
cancer cells and is required for their activity in transcription initiation. Conversely, Foxa1 
is not required for their maintenance as shown by siRNA silencing experiments (Lupien 
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et al., 2008). This data suggests an important role for Foxa proteins in chromatin 
remodeling and transcription initiation. 
1.5.4.2.3 Foxa2 function revealed by ChIP-Seq analysis 
Foxa2 has been shown to be an initiating factor in the earliest stages of liver 
development in the mouse embryo. Foxa2 was also shown to be involved in the later 
functions of the adult liver, such as bile acid and glucose homeostasis (Ang and Rossant; 
Rausa et al., 2000; Wolfrum et al., 2003). Foxa2 directly regulates genes involved in 
glucose and lipid metabolism such as glucose-6-phosphatase and tyrosine amino 
transferase (Friedman and Kaestner, 2006; Wolfrum et al., 2003). In 2008, the first study 
for the global identification of Foxa2 binding targets was performed (Wederell et al., 
2008). The authors used adult mouse liver cells for the ChIP-seq experiment. This study 
presented many new properties of Foxa2 genomic recruitment such the distribution of the 
binding events throughout the genome and the correlation of genes associated with the 
peaks and their expression in the adult liver. Interestingly, 48% of the genes expressed in 
the liver are also associated with a Foxa2 bound region. Moreover, they show that Foxa2 
binding events mostly occur within 10 Kb upstream of the transcription start site (TSS) or 
within the first intronic region, suggesting close relation of Foxa2 binding close to 
promoters. Also, a few insights have been described through de novo motif search 
performed on the data set for possible co-factors (Wederell et al., 2008).  
A more recent ChIP-seq study took a further step in analyzing the transcription 
factor characteristics of Foxa2 by assessing its interrelationship with the other members 
of this transcription factor family (Foxa1, and Foxa3). Instead of using in vivo obtained 
tissue as in the previous study they performed ChIP-seq on the Hepatocyte carcinoma cell 
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line HepG2. They found that Foxa1 and Foxa3 have dissimilar distribution of their 
binding events. Furthermore, Over 50% Foxa1 peaks overlapped with the Foxa2 peaks. 
This suggests redundancy in the functions of these two factors, and also their possible 
physical interaction. Co-immunoprecipitation (IP and ChIP-reChIP) experiments show 
that Foxa1 and Foxa2 interact and bind to similar genomic locations (Motallebipour et 
al., 2009).  
These studies are good examples of the power ChIP-seq offers for this type of 
genome wide analysis of transcription regulation and identification of novel mechanistic 
interactions.
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1.6  Aim of project 
Foxa2 has been shown to play crucial roles in the specification, development, and 
maintenance of midbrain DA neurons (Kele et al., 2006; Kittappa et al., 2007; Lin et al., 
2009). Many genes involved in this processes have been shown to be regulated by Foxa2 
(Lin et al., 2009 2006). Recent global studies of Foxa2 recruitment to the genome in adult 
mouse liver cells and liver carcinoma cell lines have given many new mechanistic 
insights to the way Foxa2 functions as a transcriptional regulator (Motallebipour et al., 
2009; Wederell et al., 2008). 
The primary aim of this project is to identify the global binding events of Foxa2 in 
the mDA neurons through ChIP-seq experiments performed at two important stages of 
their development (specification, and differentiation). The results will be used to identify 
new targets and biological processes that they are involved in. 
A secondary aim of the project is to perform enhancer analysis using newly 
identified regions from the ChIP-seq data and identify possible mechanisms driving their 
function in regulating gene expression. 
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2. Materials and Methods 
 
2.1 In Situ Hybridization 
 
Adult brains were dissected and fixed in 4% paraformaldehyde in 1M PBS 
overnight, washed in PBS and cryo-protected in 30% sucrose in PBS and sectioned on a 
Leica Jung cryostat at a thickness of 14 um. The in-situ hybridization procedure has been 
described previously (Conlon and Herrmann, 1993). Foxa1/2 probes used from Ang et al 
(1993). 
 
2.2 Immunohistochemistry 
 
Cells were fixed with, freshly made, 4% PFA for 10 min. at room temperature. 
Cells were then washed with 1X PBS. Cells were incubated for 10 min with blocking 
solution (5%FBS, 0.1% Triton, PBS). Primary Antibody was added and cells were 
incubated at 4oC over night. Cells were then washed 3X with 0.1%Triton PBS. Secondary 
Antibody was added and cells were incubated at room temperature for 1 hour. Antibodies 
used: Rabbit anti Nurr1 (Santacruz), mouse anti TH (Chemicon), rabbit anti Lmx1a (J. 
Ericsson), mouse anti Tuj1 (Chemicon), mouse anti Nestin  (Chemicon), rabbit anti 
Foxa2 (J.A. Whitsett).  
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2.3 Differentiation of ES Cells 
 
E14.1 (NesE-Lmx1a, NesE-GFP) ES cells were propagated on gelatinized culture 
dishes in DMEM (Invitrogen) supplemented with 2000 U/ml LIF (Chemicon), 10% KSR, 
2% FCS, 0.1 mM nonessential amino acids, 1 mM pyruvate (Invitrogen), and 0.1 mM b2-
mercaptoethanol (Sigma). For in vitro differentiation 15,000 cells/well were plated on 
gelatinized 24-well plates, and incubated in ES medium for 12–15 hr. Thereafter, the 
cells were washed once with PBS and grown in N2B27 differentiation medium (Ying et 
al, 2003) supplemented with 20 ng/ml bFGF (Invitrogen), 100 ng/ml FGF8, and 100 nM 
SHH for 0–8 days.  
2.4 Chromatin immunoprecipitation of in vitro and in vivo samples  
 
The samples used were prepared from cells acquired from in vitro or in vivo DA 
systems. The in vitro sample was generated from Nestin-Enhancer-Lmx1a-stably 
transfected ES cells that have been differentiated into mDA progenitors as described in 
Andersson et al 2006. The in vivo samples were prepared from dissected ventral 
midbrains of E10.5, E12.5 and E14.5 mouse embryos. Cells or tissue were cross-linked in 
1% formaldehyde for 10 min while rotating at 40 C. Cross-linking was quenched by 
adding glycine to a final concentration of 0.125 M for 5 min while rotating. The tissue 
was rinsed in cold PBS and homogenized with a plunger in cold Whole cell lysis buffer 
(10 mM Tris–Cl, pH 8.0, 10 mM NaCl, 3 mM MgCl2, 1% NP-40, 1% SDS) and protease 
inhibitors. Cells were incubated at 4°C for 10 min. Lysate was sonicated using the 
Diagenode Bioruptor for 15 min on high, using 30 s intervals. Debris were removed by 
centrifugation at 13 000 g for 10 min, and the supernatant was collected and snap frozen 
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in liquid nitrogen. A 10 uL aliquot was reverse crosslinked by the addition of NaCl to a 
final concentration of 192 mM, overnight incubation at 65°C, and purification using a 
PCR purification kit (Qiagen, CA, USA). The chromatin concentration was determined 
using a NanoDrop 3.1.0 nucleic acid assay (Agilent Technologies, Santa Clara, CA, 
USA). Ten micrograms of chromatin per sample was precleared by adding 90 uL of 
protein A-agarose in 1 ml of ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 167 
mM NaCl, 16.7 mM Tris–Cl, pH 8.1) and rotating the sample for 1 h at 4°C. Protein A-
agarose was sedimented by centrifugation at 3000 g for 30 s. Two micrograms of rabbit 
anti-Foxa2  (kind gift of J.A. Whitsett), anti-Otx2 serum or normal rabbit anti-IgG 
antibody (Millipore #12-370), was added to the supernatant and incubated overnight at 
4°C. Protein A-agarose was blocked overnight at 4°C with 1 mg/ml bovine serum 
albumin in ChIP dilution buffer, added to the chromatin, and rotated for 1 h at 4°C. 
Following three consecutive washes of 5 min each with TSE I (0.1% SDS, 1% Triton X-
100, 2 mM EDTA, 20 mM Tris–Cl, pH 8.1, 150 mM NaCl), TSE II (0.1% SDS, 1% 
Triton X-100, 2 mM EDTA, 20 mM Tris–Cl, pH 8.1, 500 mM NaCl) and ChIP buffer III 
(0.25 M LiCl, 1% NP-40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris–Cl, pH 8.1), 
chromatin was eluted by adding 100 uL of freshly made ChIP elution buffer (1% SDS, 
0.1 M NHCO3) to the pellet and rotating the sample for 10 min. Elution was repeated 
with an additional 100 uL of ChIP elution buffer, and the eluates were combined. Cross-
linking was reversed by the addition of NaCl to a final concentration of 192 mM and 
overnight incubation at 65°C. The samples were resuspended in Tris-EDTA  
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2.5 Real-time qPCR 
 
 ChIP-qPCRs were assembled using Platinum SYBR Green Super mix 
(Invitrogen). Reactions were performed in triplicates using the ABI 7900 PCR System 
(ABI). The enrichment was calculated by comparing input (sheared genomic DNA) to 
ChIP material (2Ct input-Ct ChIP). The enrichment of Foxa2 target regions was compared 
to regions close to the Gli2 and Shh loci (-ve 1, and –ve 2 respectively), which served as 
a reference for nonspecific DNA. One-way Annova and Dannet test was used to calculate 
the significance of enrichment of the target region over the negative control region (-ve 
1). 
  Primers were designed using the Primer3 sofware (www.biotools.umassmed.edu). 
All primers were tested using multiple dilutions of input genomic DNA and dissociation 
curve was set to make sure a single product was generated. Primers are provided in the 
Appendix chapters. 
 
2.6 ChIP followed by high throughput sequencing 
 
For ChIP-Seq experiments, for the purpose of collecting enough of the 
immunoprecipitated DNA, 20 independent ChIP assays were performed as described 
previously and were finally collected in a single PCR purification column (Qiagen). For 
the in vitro system 107 cells were required. As for, the in vivo samples required 80 E12.5 
and 40 E14.5 ventral midbrains respectively. As control sample we used input DNA. 
10ng of the ChIP (experiment) or input (control) DNA samples were modified for 
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sequencing following the manufacturer’s protocol (Illumina). Cluster generation and 
sequence alignment to the mouse genome (mm9) with subsequent pipeline processing 
were performed following Illumina’s protocol. Note, two lanes were sequenced for each 
sample and merged the tags for deeper sequencing purposes. 
 
2.7 Peak calling using a model based analysis of ChIP-seq (MACS) 
MACS analyses the ChIP-seq tags of the experiment against the control sample 
(Input). MACS linearly scales the total control tag count to be the same as the total ChIP 
tag count. Since there may be tags that are sequenced repeatedly, more times than 
expected from a random genome-wide tag distribution. Such tags might arise from biases 
during amplification of the ChIP sample and preparation of the sequencing library, and 
are likely to add noise to the final peak calls. Therefore, MACS removes duplicate tags 
higher in number than what is expected. 
The program then Slides 2 dimensional windows across the genome to find 
candidate peaks with a significant tag enrichment (p value 10e-5). It will then merge 
overlap peaks, and extend each tag a fixed number of bases from its center. For each 
candidate peak, the window is centered at the peak location in the control sample and a p-
value is calculated and the false peaks are removed. Peaks with p-value below 10e-5 are 
called (positive peaks). 
The false discovery rate (FDR) is calculated by reversing the control and treatment 
data, calling peaks using the same strategy, and then calculating p-values for these 
'negative peaks'. After ranking 'positive' peaks and 'negative' peaks by p-values, one can 
 67 
calculate an FDR for a certain p-value and is the #control peaks/#ChIP peaks for that p-
value. 
2.8 Motif analysis 
To determine the de novo sequence recognized by Foxa2 in our ChIP-Seq data set 
we performed the ultra conserved motif search using MEME (www.meme.sdsc.edu). First 
we sorted our list according to the FDR, low FDR peaks being at the top of the list and 
the higher FDR peaks being at the bottom of the list. The peaks were then grouped in 
groups of 500 peaks, generating 19 groups. The subpeak regions of 60 bp spanning the 
peak summits from each group were uploaded on MEME and the default parameters 
were used to do the search. 
To search the ChIP-Seq data set for possible enrichment of the Otx2 motif, the 
position weight matrix provided by Uniprobe (www.thebrain.bwh.harvard.edu/uniprobe) 
was used to search the data set using the Perl module TFBS by Boris Lenhard (Lenhard 
and Wasserman, 2002). The score threshold was set at 80% similarity. Based on these 
parameters 629 peak sequences were found to contain the Otx2 PWM. To establish 
statistical confidence for the motif search results 1000 random datasets, were generated, 
each with the same number of sequences as the ChIP-Seq dataset, and with the same 
dinucleotide composition. The same parameters were used to search for the Otx2 PWM 
in these random data sets. 
2.9 Gene Ontology (GO) analysis 
 
The identfication (ID) numbers of the genes used for this analysis were extracted 
from MGI (www.informatics.jax.org). These IDs were used as reference on 
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GOTOOLBOX (www.genome.crg.es/GOToolBox) to identify the overrepresented GO 
terms. GO categories were taken from the ‘‘biological process’’ level. Only terms with p-
value <0.001 were considered for the analysis and the Fold enrichment of the genes 
found in our list over the reference (whole genome) were calculated for each GO term. 
Genes in the top terms identified for each category studied can be found in the Appendix 
chapter. 
 
2.10 Breeding and genotyping of mutant animals.  
 
All mouse strains were maintained in a mixed MF1-129/SV background. En1KICre/+, 
Foxa2flox/ flox and Foxa1 loxp/loxp mouse strains were generated as described (Sapir et al., 
2004; Hallonet et al., 2002; Gao et al., 20008 respectively). In this thesis, the Foxa1loxp 
allele will be referred as Foxa1flox.  Foxa2 flox/ flox;Foxa1 flox/ flox mice were generated by 
crossing  Foxa2flox/flox  with Foxa1flox/flox animals. To obtain conditional Foxa1/2 double 
mutants, En1KICre/+ mice were crossed with Foxa2flox/flox;Foxa1 flox/ flox animals. 
Subsequently, En1KICre/+;Foxa1fl1ox/+;Foxa2flox/+ F1 male animals were then mated to 
Foxa2 flox/ flox;Foxa1 flox/ flox females to generate En1KIcre/ + ;Foxa2 flox/ flox;Foxa1 flox/ flox 
double mutants. The Foxa2flox and Foxa1flox alleles were detected by PCR (Hallonet et al., 
2002; Gao et al., 2008), whereas the Cre transgene was detected by using a pair of 
primers and PCR conditions as described by Indra et al. (1999). 
The En1Cre/+; Otx2flox/flox and Nestin Cre/+, Foxa2 flox/ flox;Foxa1 flox/ flox  mice have been 
described previously (Kele et al., 2006; Puelles et al., 2004).  
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2.11 RNA extraction 
 
Single E10.5 dissected ventral midbrain tissue or 500 X 103 Cells harvested at day 
2, day 3.5 and day 5 of in vitro diffrentiation were collected in the RNA extraction buffer 
provided by the Pico pure RNA extraction kit (ARCTURUS). RNA was extracted 
according to manufacturers specifications.  
 
2.12 Reverse transcriptase qPCR analysis  
 
The cDNA was prepared from in vitro differentiated NesE-Lmx1a Es cells or E10.5 
single dissected mouse ventral midbrain of the mutant strains described previously. The 
Pico Pure kit (Arcturus) was used to extract the RNA. Total RNA were transcribed into 
cDNA with the SuperScriptTM III RT (Invitrogen, Carlsbad, CA) and oligo (dT) primers. 
For quantitative analysis of the expression level of mRNAs, real-time PCR analyses 
using Platinum SYBR Green Super mix (Invitrogen) were performed in triplicates using 
the ABI 7900 PCR System (ABI). Oligonucleotides amplifying small amplicons were 
designed using Primer3 (biotools) software. Amplifications were performed in 20 µl 
containing 0.5 µM of each primer. 0.5 X SYBR Green (Invitrogen), and 2 µl of 50 fold 
diluted cDNA.  Forty-five PCR cycles were performed with a temperature profile 
consisting of 95oC for 30 sec, 60oC for 30 sec, 72oC for 30 sec, and 79oC for 5 sec.  The 
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dissociation curve of each PCR product was determined to ensure that the observed 
fluorescent signals were only from specific PCR products. After each PCR cycle, the 
fluorescent signals were detected at 79oC. The fluorescent signals from specific PCR 
products of cDNA prepared from mutant or control (wild type littermate) ventral 
midbrain tissue were normalized against that of the GAPDH gene (2Ct GAPDH-Ct Gene 
tested), and then relative values were calculated by setting the normalized value of control 
as 1.  All reactions were repeated using at least three independent samples (biological 
replicates), and One-way Annova and Dannet test was used to calculate the significance 
of the fold change of the expression of genes tested in mutant compared to the wild type 
control. 
2.13 Illumina Array Hybridization 
Biotinylated cRNA were prepared from 500 ng of total RNA using an Illumina 
TotalPrep RNA Amplification Kit (Ambion, TX) and cRNA yields were quantified using 
an ND-1000 spectrophotometer (Nanodrop Technologies). cRNA (1500 ng) were 
hybridized to Illumina's MouseRef-8 v2.0 expression BeadChips (Illumina) containing 
25,000 mouse genes using the hybridization solution supplied by the manufacturer. All 
reagents and procedures for washing, detection, and scanning were performed according 
to the Beads Station  system protocols. 
2.14  Luciferase Assay (Promega) 
P19 cells were transfected with constructs containing candidate regulatory elements 
upstream of a luciferase gene to measure their enhancer activity. Foxa2 candidate 
cofactors (Otx2, Lmx1a, and Nurr1) including Foxa2 were cloned down stream the CMV 
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promoter. All transfection plasmid constructs were purified by the Qiagen Maxi-prep 
method. For each experiment, individual sample plasmids were tested in triplicate. 200 
nanograms of sample plasmid DNA were introduced into P19 cells by the Lipofectamine 
method (Invitrogen). All plasmids tested were cotransfected with 10 ng of Renilla to 
control for transfection efficiency.. The empty luciferase vector was used as a negative 
control. Cells were grown in the appropriate media for 2 days after subculturing onto 20 
well tissue culture plates to a density of 5 Χ 10 4 cells/well. Cells were assayed for 
luciferase activity using the Promega luciferase assay kit and the analytical luminescence 
monolight luminometer. Relative light units were determined after a 10-s detection 
period. The ratio of luciferase activity Luciferase construct/ Renilla was determined, and 
the average of triplicate readings was expressed as fold expression over background 
(activity of the empty luciferase vector) 
  
2.15 Generation of Reporter Constructs 
Genomic sequences bound by Foxa2 within the Lmx1a and Lmx1b loci were PCR 
amplified uding high fidelity Taq (Roche) Fragments were subcloned into the TOPO 
vector (Invitrogen) and directly sequenced using the T7 promoter. The reporter construct 
used for the transgenic studies was BGZA, which contains the β-globin minimal 
promoter, lacZ gene, and SV40 polyadenylation cassette (Helms et al., 2000; Yee and 
Rigby, 1993). The fragments were then cloned into the Sal1, Nhe1 site upstream of the β-
globin minimal promoter. The primers used are: 
Lmx1a CR1 
F: TTGTAAGCTTCTCTGCCCAGTTCCCCAGGA 
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R: AGAAGCTTGCTCTGTTTCCACCCTCTCCAC 
      Lmx1a CR2 
F: AGGCTGAAGCTTCACACCCGGACGGCAGTTTT 
R: CAAAGCTTGCCGGCCCGAAGGCGCGGCCCCG 
Lmx1b CR1 
F: AAGAAGCTTCAGGCAGCCAGGGGTTAA 
R: AAAAGCTTGTGTGTGTGTGTGTGTGTG 
 
2.16 Production and genotyping of transgenic mice 
Transgenes were prepared for microinjection as described (Epstein et al., 1996). 
The genotyping of transgenic embryos was carried out by PCR using proteinase K 
digested tail biopsies as DNA templates. Primers directed against lacZ (F: 
GCACATCCCCCTTTCGCCAGCTGGCGTAAT)(R:CGCGTCTGGCCTTCCTGTAGCCAGC
TTTCA), generating DNA fragments of (220 bp), were used under the following PCR 
conditions: 94°C for 1 minute, 60°C for 1 minute, 72°C for 1 minute, for 30 rounds 
followed by a final extension at 72°C for 10 minutes. For staging embryos, the day of 
vaginal plug detection corresponded to 0.5 days post coitus (dpc). 
 
2.17 Whole-mount β-galactosidase  
β-galactosidase activity was detected in whole-mount embryos by using X-gal 
(Sigma) as substrate according to Echelard et al. (1994). The embryos were stained from 
60 minutes to overnight depending on the strength of transgene expression.  
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3. Results 
 
In this study, we identified and analyzed genomic regions bound by Foxa2 in DA 
cells during specification and differentiation. ChIP-qPCR experiments were performed 
for the purpose of validating the sites identified through genome wide ChIP-Seq analysis. 
RT-qPCR expression analysis of the candidate target genes was investigated in loss of 
function models to establish the functionality of the protein/DNA interaction. To identify 
the possible biological processes Foxa2 may be involved in regulating we performed GO 
term analysis of Foxa2 candidate target genes. The names of genes mentioned in this 
thesis, as well as the associated chromosomal regions tested in the independent ChIP-
qPCR assays are summarized in the appendix chapters.  
 
3.1 Genome wide analysis of Foxa2 binding in an in vitro model for 
midbrain DA progenitors 
Foxa1 and Foxa2 start being expressed in the mouse ventral midbrain progenitors 
at E8.5 (Hahn et al., 1993). By E10.5 the midbrain progenitor cells express all the 
markers defining a mDA precursor, such as Lmx1a, Lmx1b, Foxa2, and Shh, but none of 
the immature and mature neuronal markers such as Nurr1, AADC, Th, DAT, and Pitx3 
are expressed at this point (Kele et al., 2006). From a developmental point of view, E10.5 
is the proper time point to harvest primary ventral midbrain cells to perform ChIP-Seq. 
An obstacle for this is that ChIP-seq requires 20 million cells for the analysis and it is 
extremely difficult and time consuming to dissect enough E10.5 ventral midbrain tissue 
for a ChIP-Seq experiment. For this reason we decided to use an in vitro cell line system 
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of mDA progenitors character to identify Foxa2 target genes during the specification of 
these neurons.  
3.1.1 Defining the in vitro midbrain DA progenitor model 
During this thesis there were a number of in vitro models for mDA neurons to 
consider, such as in vitro differentiation of ES cells. The protocol by Kawasaki et. al. 
demanded differentiation of ES cells over a stromal cell line, whereas the protocol by Lee 
et al required cell aggregation and application of Fgf8 and Shh in the media to induce the 
proper cell fate (Kawasaki et al., 2000; Lee et al., 2000). Ying et al offered an alternative 
method by differentiating ES cells as an adherent monolayer culture to produce DA 
neurons upon the addition of Fgf8 and Shh to the serum free media (Ying et al., 2003). 
None of these methods using ES cells produce DA neurons efficiently with the proper 
markers that define ventral midbrain DA neurons (Andersson et al., 2006b; Kawasaki et 
al., 2000; Lee et al., 2000). These approaches result in a largely heterogeneous population 
that cannot be used for this experiment. Another cell line to consider is known as MN9D 
(Rick et al., 2006). MN9D is an immortalized cell line resulting from the fusion of mouse 
neuroblastoma and ventral midbrain DA neurons. These cells express TH, and also 
produce and transport DA (Rick et al., 2006). Due to the fact that MN9D cells express 
mature mDA markers rendering them unsuitable for use in this experiment since we aim 
at strictly using cells with a DA progenitor character. 
The identification of Lmx1a as an intrinsic determinant of mDA neuron 
differentiation made it possible to produce high yields of mDA progenitors in vitro 
(Andersson et al., 2006b). The method utilizes ES cells transgenic for Lmx1a driven by 
the promoter of the neural stem cell marker Nestin. The experiment requires 8 days of 
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differentiation. By day 5 the cells express most if not all the known midbrain DA 
progenitor markers including Foxa2 and Lmx1a as shown by immunofluorescence, and 
microarray expression analysis (Figures 3-1, 3-4).  
 
 
 
 
 
 
By day 8 a large percentage of the colonies (over 80%) express mature mDA 
neuronal markers and acquire neuronal morphology (Figure 3-2). As a control experiment 
we differentiated ES cells transgenic for GFP under the Nestin enhancer using the same 
culture conditions as the previous case. We observed that the efficiency of generating 
TH+ neurons is very low (below 10% of colonies express TH); suggesting that the 
transgenic NesE-Lmx1a ES cell line is the proper cell line to use for our experiments 
(Figure 3-3). 
Foxa2 
Nestin 
Dapi 
D E F 
Lmx1a 
Nestin 
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Lmx1a  
 
Nestin 
 
Foxa2 
 
Figure 3-1: Foxa2 and Lmx1a expression after 5 days of in vitro monolayer differentiation of 
NesE-Lmx1a transgenic ES cells.  
(A-C) Lmx1a and Nestin staining followed by counter staining with Dapi. (D-F) Foxa2 and 
Nestin staining followed by counter staining with Dapi. 
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Figure 3-2: Expression profile of neurons generated at day 8 (D8) of in vitro differentiation of 
NesE-Lmx1a transgenic Es cells. 
 (A-C) TH overlap with Tuj1. (D-F) TH overlap with Nurr1. (G-I) TH overlap with Foxa2. TH+ 
neurons are generated with high efficiency by D8, and immuno-histochemical staining suggest co-
expression of Nurr1 and Foxa2. Dapi was used as counter staining in all cases. 
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3.1.1.1 Day 5 of in vitro differentiation of NesE-Lmx1a transgenic Es cells is the 
best time point to harvest mDA progenitors for ChIP-Seq 
Illumina expression arrays were used to profile the cells during their initial stages of 
differentiation at the defined time points, Day 2 (D2), Day 3.5 (D3.5), and Day 5 (D5). 
The expression dynamics of known genes normally expressed in the ventral midbrain 
were assessed at these time points (Figure 2-4). Interestingly, most of the progenitor 
marker genes detected such as TCF12 (E-box protein expressed in the ventricular zone), 
Corin (floor plate marker) and Bmp7 reach a peak of expression at D5 and more 
importantly none of the known mature markers (TH, and AADC) were expressed at this 
time point (Uittenbogaard and Chiaramello, 2002; Mavromatakis, 2006). Importantly, 
Shh, a target of Foxa2, was expressed by day 5, and ChIP-qPCR experiments with Foxa2 
antiserum on day 5 show that Foxa2 is bound to its target regions on the Shh and Foxa2 
regulatory elements (Figure 3-5). This result suggests that Foxa2 is exerting its regulatory 
Tuj1 
TH/Dapi 
A B C 
Tuj1 TH 
Figure 3-3: Expression profile of neurons generated from the in vitro differentiation of NesE-GFP 
transgenic Es cells.  
(A-C) Overlap of TH with Tuj1 and counter staining with Dapi . TH+ neurons are produced at very 
low efficiency from an Lmx1a negative context. 
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influence on its target genes at D5. All together, this data shows us that D5 is a suitable 
time point to harvest the differentiated cells for the ChIP-Seq experiment. 
 
 
 
 
 
 
 
 
Figure 3-4: Microarray analysis of the expression profile of NesE-Lmx1a ES cells 
during differentiation towards midbrain DA progenitors.  
Genes presented: Foxa2, Shh, Lmx1a, Slit2, Tcf12, Corin, Bmp7, and Nestin. We 
observe the expression of all these genes arriving at a peak on day 5 (D5) of in vitro 
differentiation. 
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Figure 3-5:ChIP experiments of chromatin from D5 in vitro differentiated mDA 
progenitors validating the positive control regions, Shh brain enhancer and the 
Foxa2 floor plate enhancer using Foxa2 antiserum.  
Non-specific antibody against IgG was used for the mock ChIP assays. Error 
bars represent SEM. Each ChIP was performed on chromatin samples from 
three biological replicates, and enrichment of both control regions over the 
mock experiments was statistically significant (P < 0.05) 
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3.1.2 Identification and characterization of Foxa2 DNA binding in vitro 
3.1.2.1 Identification of Foxa2 DNA binding events 
Chromatin immunoprecipitation and massively parallel Illumina 2G sequencing 
(ChIP–Seq) were carried out to identify binding sites of Foxa2 in mDA progenitors derived 
from our in vitro D5 differentiated NesE-Lmx1a ES cells (Andersson et al., 2006b). 
Sequencing of the ChIP product generated ~107 high quality sequences that mapped to the 
mouse genome and are viewed by the UCSC mm9 genome browser 
(www.genome.ucsc.edu). Peaks were called by a model-based analysis of ChIP-Seq  
(MACS), and overlapping mapped sequences represent Foxa2 bound regions (Zhang et al., 
2008). By normalizing the ChIP experiment to an input control, a false discovery rate 
(FDR) was assigned to each peak and false peaks were removed from the list. We identified 
9160 peaks with an FDR substantially lower than 5%, providing a good level of confidence. 
To further establish the quality of the list we examined the known regulatory regions bound 
by Foxa2, the Shh brain enhancer and the Foxa2 floor plate enhancer using the UCSC 
genome browser (Jeong and Epstein, 2003; Nishizaki et al., 2001). Statisctorily, clear peaks 
could be identified in these regions providing initial confidence in the data set (Figure3-6). 
Furthermore, Foxa2 regulated genes identified in the lab from mouse genetic data such as 
Lmx1a, lmx1b, and Foxa1 are only a few examples of genes that have been associated with 
a peak from our list (Figure 3-7) (Lin et al., 2009; Mavromatakis, 2006). Two Regions 
bound by Foxa2 on each of the Lmx1a and Lmx1b loci have been studied in this thesis and 
will be known from now on as Lmx1a or Lmx1b Conserved Regions 1 and Conserved 
Regions 2 (CR1 and CR2 respectively) due to the high conservation of their sequence 
between many species (Figure 3-7). 
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Figure 3-6: Occupancy of Shh and Foxa2 conserved regulatory elements by Foxa2.  
(A) Schematic diagrams of the Shh brain and Foxa2 floor plate enhancers indicating peak regions 
generated from data obtained by Foxa2 in vitro ChIP-Seq experiments. (B) ChIP experiments of 
chromatin from E12.5 ventral midbrain tissue validating the positive control regions, Shh brain 
enhancer and the Foxa2 floor plate enhancer using Foxa2 anti serum. Genomic regions  (-ve1, -ve2) 
unbound by Foxa2 were used as negative control. Error bars represent SEM. Each ChIP was 
performed on chromatin samples from three biological replicates, and enrichment of both control 
regions over the negative regions in the ChIP samples was statistically significant (P < 0.05).  
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Figure 3-7: Occupancy of Lmx1a and Lmx1b conserved genomic elements by Foxa2.  
(A-B) Schematic diagrams of genomic regions occupied by Foxa2 within the Lmx1a and Lmx1b loci 
from data obtained by Foxa2 in vitro ChIP-Seq experiments. Red arrows indicate peaks called by 
peak calling algorithm MACS. CR1: First conserved region. CR2: Second conserved region. 
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3.1.2.2 DNA binding motifs enriched in our data set 
To determine the de novo sequence recognized by Foxa2 in our ChIP-Seq data set 
we performed a motif search using MEME (www.meme.sdsc.edu) to look for the best two 
motifs. First we sorted our list according to the FDR, low FDR peaks being at the top of the 
list and the higher FDR peaks being at the bottom of the list. The peaks were then grouped 
in groups of 500 peaks, generating 19 groups. The subpeak regions of 60 bp spanning the 
peak summits from each group were uploaded on MEME and the default parameters were 
used to do the search. The first motif was a Foxa2 motif defined by the JASPAR database 
(Bryne et al., 2008), and was enriched throughout the data set confirming further the 
validity of the results (Figure 3-8A). Furthermore, a second motif was identified using this 
method that greatly resembled an E-box motif as defined by the TRANSFAC database 
(Matys et al., 2006) similar to the Mash1 binding motif (Figure 3-8B). Mash1 is a basic 
helix loop helix transcription factor and is involved in neuronal differentiation and 
development. Mash1 acts as a transcription activator by binding on E-box sequences within 
promoters and enhancers of its target genes (Castro et al., 2006). These data suggests Foxa2 
may be co-occupying genomic regions together with an E-box binding protein. 
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Figure 3-8: De novo motifs identified from the ChIP-seq analysis. 
(A) Sequence of first de novo motif enriched in the ChIP-Seq data as identified by MEME. (B) Represents 
the known Foxa2 DNA binding motif present in the JASPAR database. (C) Sequence of the E-box motif 
(Castro et al., 2006) commonly bound by Mash1 (top). Sequence of the second enriched de novo motif 
identified by MEME in the data set (bottom). 
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3.1.2.3 Characterizing the locations of the high confidence peaks 
The locations of the high-confidence peaks were mapped to the nearest TSS of 
Ensembl annotated genes, and microRNA transcripts. We found that 47% of peaks were 
located within a gene region (Figure 3-9). Interestingly, only 8% of the peaks were 
located within 2 kb upstream or downstream of the TSS of annotated genes, while 27.8% 
of the peaks were located within 10 kb of the TSS (Figure 3-10A). 30% of peaks 
overlapping genes were localized to a first intron (Figure 3-10B). We also observed that 
40% of all peaks were more than 100 kb from the TSS of any annotated gene (Figure 3-
10C). Of these peaks, 45% overlapped with conserved genomic regions, suggesting that 
either Foxa2 may act at remote distances from genes or that a number of Foxa2-regulated 
genes have yet to be annotated. Thus, Foxa2-binding sites observed are not preferentially 
located close to an annotated TSS but are situated at a range of locations across the 
mouse genome. 
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Figure 3-9: Percentage of binding sites at various distances from and within genes. 
Recruitment at distal regions from or within genes is a general characteristic of Foxa2 
binding. 47% of peaks identified are within genes. 
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3.1.2.4 Validation of Foxa2 in vitro binding events using E12.5 mouse ventral 
midbrain tissue by ChIP-qPCR 
Binding events that occur in vitro may not be a direct indication of binding events 
occurring in vivo. To test our in vitro model we chose a group of 11 peaks assigned to 
genes expressed at E12.5 in the mouse ventral midbrain. We then performed ChIP-qPCR 
experiments using E12.5 mouse midbrain tissue to test these 11 regions. It was very 
encouraging to see that all sites were enriched in the independent Foxa2 ChIP (Figure 3-
11). This suggests that many regions bound by Foxa2 in the in vitro data set can be 
verified by independent detection methods (ChIP-qPCR) in the relevant in vivo system.  
 
 
Figure 3-10: Characteristics of Foxa2 genome wide DNA binding events (in vitro). 
(A) Percentage of binding sites at various distances from TSS. Recruitment at distal regions 
from the TSS is a general characteristic of Foxa2 genomic recruitment. (B) Distribution of 
peaks within genes. Majority of peaks are distributed within intronic regions with 30% 
identified within the first intron. (C) Distribution of the peaks from the nearest downstream 
gene. Most of the peaks are found between 10 and 100 kb away from the nearest downstream 
gene. 
 90 
 
3.1.2.5 Overlap of ChIP-Seq data with microarray expression data 
The candidate target genes from the ChIP-Seq experiment were correlated with 
differentially expressed (DE) genes identified from the microarray time course assay of in 
vitro differentiated mDA progenitors described previously. Only DE genes with a p value 
<0.01 were considered. We observed that 25% of the DE genes correlated with a peak. 
Out of these peaks 16% are within 2kb of the TSS, 34% are within 10kb, and 72% are 
within 50kb (Table 1). This observation enhances the previous suggestion that Foxa2 
may exert it regulatory influence on gene expression from genomic regions at remote 
distances in DA progenitor cells. 
 
 
 
 
 
 
 
 
 
Figure 3-11: Genomic regions validated for Foxa2 binding by an independent ChIP-qPCR assay. 
ChIP was performed on chromatin extracted from ventral midbrain of E12.5 mouse embryos. All 
15 regions tested are enriched compared to negative control regions. Error bars represent SEM. 
Each ChIP was performed on chromatin samples from three biological replicates, and enrichment 
Foxa2 bound regions over the negative regions in the ChIP samples was statistically significant 
(* P value < 0.05).  
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3.1.2.6 GO term analysis of Foxa2 DE target genes identified in vitro  
To globally categorize the types of genes that are differentially regulated by Foxa2, 
we determined the enriched Gene Ontology (GO) functional categories that are among 
genes either up regulated or down regulated between D3.5 and D5, since this is the time 
point Foxa2 is reaching its peak of expression (Figure 3-4). We found that the up 
regulated candidate target genes are enriched for neuronal differentiation processes, 
whereas the down regulated set of targets are enriched for genes involved in alternative 
cell fate processes such as cardiac muscle and immune system development (Figure 3-12, 
3-13).  
 
# Peaks 9160 
# DE genes in microarray time course 3326 
# DE genes with a peak  824 
# Peaks within 2kb of DE gene TSS 160 (16%) 
# Peaks within 10kb of DE gene TSS 341 (34%) 
# Peaks within 50kb of DE gene TSS 720 (72%) 
Table 1. Distribution of Foxa2 peaks from the TSS of candidate targets. 
Most of the binding events are observed far away from the TSS. 
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:Figure 3-12: Gene ontology (GO) categories showing the most enriched 
biological processes of up regulated candidate targets in the system between D3.5 
and D5 of in vitro differentiation. 
 All categories displayed are of p-value<0.001 and are sorted according to fold 
change of the number of genes in each biological process in the experiment list 
over the reference list (whole genome). 
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Figure 3-13: Gene ontology (GO) categories showing the most enriched biological 
processes of down regulated candidate targets between D3.5 and D5 of in vitro 
differentiation.  
All categories displayed are of p-value<0.001 and are sorted according to fold 
change of the number of genes in the experiment list over the reference list  (whole 
genome) for each biological process. 
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Although these functional categories are quite broad, they are consistent with the 
function of Foxa2 in promoting neuronal differentiation and possibly inhibiting the 
development of alternative cell fates. In order to validate the target genes in these 
categories we identified the transcription factors together and other genes involved in 
diverse functions such as, Bmp7 (Bmp signaling), Corin (floor plate marker), Axin2 (Wnt 
signaling target), Fgr2 (Fgf8 receptor), Slit2 (migration process). Initially we tested the 
sites bound by Foxa2 in vitro through ChIP-qPCR assays performed on chromatin from 
E12.5 ventral midbrain tissue. A large proportion of the sites (80%) validated by the 
independent ChIP-qPCR assays (Figure 3-15). The 20% of bound regions that did not 
validate may be bound at earlier developmental time points. We next assayed the 
functional relevance of Foxa2 binding to these target genes. For the loss of function 
model we used the En1Cre/+;Foxa1flox/flox;Foxa2flox/flox mutant mice, since using En1 Cre/+ 
will affect the mDA cells at the progenitor (E10.5) stage.(Lin et al., 2009). The ventral 
midbrain was dissected from these mutants and the mRNA expression of candidate genes 
was compared to their wild type littermates by qPCR. Over 50% of the genes tested were 
affected in these mutants (Figure 3-14, 3-19). These results gave us the confidence that a 
significant proportion of the genes described as direct targets of Foxa2 will also be under 
its direct regulation. Interestingly, genes regarded as intrinsic determinants of mDA 
neuron specification (Lmx1a, and Lmx1b) are Foxa2 direct targets supporting further a 
direct role of Foxa2 in mDA specification (Huangfu and Anderson, 2006). 
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Figure 3-14: Validation of Foxa2 targets in ventral midbrain progenitors of 
En1Cre/+;Foxa1flox/flox;Foxa2flox/flox mice at E10.5. 
 Expression analysis by qPCR of candidate target transcription factors (TF), 
and genes involved in other functions. Foxa1 and Foxa2 are used as controls. * 
Fold change between mutant and its wild type littermate (Control) is 
statistically significant with p-value<0.05. 
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3.1.2.7 E-box motif is enriched in regions associated with up regulated genes 
involved in neuron development 
The E-box motif identified as highly enriched in our ChIP-Seq data has been 
found in 1065 regions bound by Foxa2. Of these regions, 65 overlapped with up-
regulated genes from the in vitro time course microarray expression assay. GO term 
analysis suggests the involvement of the up regulated genes in biological processes such 
as axon guidance, neuron maturation and neurogenesis supporting the assumption of an 
E-box binding protein possibly cooperating with Foxa2 in the induction of these genes 
(Figure 3-16). Only 14 down-regulated genes were associated with these genomic 
regions, which imply the correlation of this E-box sequence with transcription activation 
rather than repression.  
 
 
Figure 3-15: Validation of ChIP-seq results by independent ChIP-qPCR experiments 
performed using chromatin from E12.5 mouse ventral midbrain.  
80% of the regions tested are enriched compared to negative control region. Primers 
amplifying a region in the Gli2 locus were used as negative control. Element 5 (E5) 
represents Foxa2 bound region in the Gli2 locus used as positive control.  Error bars 
represent SEM. Each ChIP was performed on chromatin samples from three 
biological replicates. * Enrichment of Foxa2 bound regions over the negative region 
in the ChIP samples was statistically significant (P < 0.05). 
 98 
 
 
 
 
 
 
 
 
 
3.1.2.8 Otx2: a possible cofactor for Foxa2 function in DA progenitor specification 
Otx2 has recently been discovered to control the proliferating activity of midbrain 
DA progenitors and is also required to promote differentiation by activating the 
expression of Lmx1a either directly or indirectly (Omodei et al., 2008). Furthermore, 
Otx2 is suggested to regulate Shh expression and positioning in the system. (Omodei et 
al., 2008). Since Otx2 is also required for regulating Foxa2 direct targets, Shh and 
Figure 3-16: Gene ontology (GO) categories showing the most enriched biological processes 
of up regulated candidate targets between D3.5 and D5 of in vitro differentiation containing 
the enriched E-box sequence identified from the data set. 
 All categories displayed are of p-value<0.001 and are sorted according to fold change of the 
number of genes in the experiment list over the reference list  (whole genome) for each 
biological process. 
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Lmx1a, we chose to test if Otx2 binds directly to the genomic regions identified to be 
bound by Foxa2. ChIP-qPCR experiments were performed on E12.5 ventral midbrain 
tissue using Otx2 antiserum to capture Otx2 bound genomic regions. All the regions 
tested contained an Otx2 DNA binding motif that enhance the possibility of an Otx2 
interaction. The selected regions were Lmx1a CR2, Lmx1b CR1, Slit2, and Shh brain 
enhancer. Interestingly, Otx2 antiserum ChIP enriched for all the regions except for Slit2, 
and suggests the possible direct involvement of Otx2 in regulating these genes (Figure 3-
17).  
  
 
 
 
 
 
Figure 3-17: ChIP-qPCR experiments performed using chromatin from E12.5 mouse 
ventral midbrain using Otx2 specific antiserum. 
 All regions tested are enriched compared to negative control region except for the Slit2 
genomic region. Primers of an Otx2 unbound region in the Gli2 locus was used as 
negative control.. Error bars represent SEM. Each ChIP was performed on chromatin 
samples from three biological replicates. * Enrichment of Otx2 bound regions over the 
negative region in the ChIP samples was statistically significant (P < 0.05). 
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Otx2 binding to similar regions as Foxa2 lead us to ask the questions: is Otx2 a 
Foxa2 cofactor and are there more regions bound by both factors leading to more genes 
being co-regulated? To answer the first question we searched the FANTOM 4 database 
where data from a large-scale mammalian two-hybrid screen performed using cDNA of 
transcription factors in human provided a large pool of information for possible physical 
interactions. Surprisingly, the search identified only a few genes including Otx2 as being 
co-factors of Foxa2 (Figure 3-18). 
 
 
 
 
 
 
Figure 3-18: Possible Foxa2 cofactors predicted by FANTOM4. (A) Table of 
candidate Foxa2 cofactors and their respective gene names. (B) In purple, spheres 
connected by lines indicate the occurrence of physical interactions between the two 
factors sharing each end of the line.  
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To answer the second question, we decided to search the ChIP-seq data set for 
possible enrichment of the Otx2 motif.  The position weight matrix from Harvard 
Uniprobe database was used to search the data set (www.thebrain.bwh.harvard.edu). 
From this search 629 sequences were found to contain the Otx2 PWM. To establish 
statistical confidence for the motif search results, 1000 random datasets were generated, 
each with the same number of sequences as the ChIP-seq dataset, and with the same 
deoxynucleotide composition. The same parameters were used to search for the Otx2 
PWM in these random data sets. We found that the Otx2 PWM was not enriched in the 
random data sets compared to the Foxa2 ChIP-Seq data with a significance of P 
value<0.01. Furthermore the TSS of 54 up-regulated genes overlapped with these 629 
genomic regions. This data suggests that Foxa2 together with Otx2 may regulate a subset 
of the genes up regulated in the in vitro system. 
 In order to test this hypothesis, we analyzed the expression of the 54 genes that 
correlate with an Otx2 binding motif, in the ventral midbrain of both E10.5, 
En1Cre/+;Foxa1flox/flox;Foxa2flox/flox and En1Cre/+;Otx2flox/flox mutant mice. Of the 54 genes 
tested in the En1Cre/+;Foxa1flox/flox;Foxa2flox/flox mice, 24 were differentially regulated 
(Figure 3-19). Furthermore, 11 out of 24 Foxa2 dependant genes were also differentially 
expressed in the En1Cre/+;Otx2flox/flox mutant mice (Figure 3-20). These 11 genes are the 
most likely to require both Foxa2 and Otx2 direct inputs for their proper regulation. 
ChIP-qPCR experiments need to be performed using Otx2 antiserum to further validate 
the possible binding of Otx2 to these regions. (Please note, Slit2, Bmp7, Lmx1a, Lmx1b 
have been analyzed in Figure 3-14) 
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Figure 3-19: qPCR expression analysis of Foxa2 target genes that may be coregulated by 
Otx2.in ventral midbrains of En1Cre/+;Foxa1flox/flox;Foxa2flox/flox mice at E10.5. (A-C) Of the 
54 genes with genomic regions bound by Foxa2, that contains an Otx2 DNA binding motif 
24 are differentially expressed within these mutants.  * Fold change between mutant and 
wild type littermate (Control) is statistically significant with p-value<0.05. 
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3.1.2.9 Predictions of physical interaction of transcription factors regulated by 
Foxa2 in vitro 
 Transcriptional regulatory networks drive tissue specific spatial and temporal 
patterns of gene expression (Naef and Huelsken, 2005). These networks usually involve 
the assembly of transcription factors on DNA target promoter sequences of genes they 
regulate. Often these transcription factors do not act independently but form complexes 
with other transcription factors and members of the transcription regulation machinery 
(Ravasi et al., 2010). To test this hypothesis in our system, we used the Foxa2-bound 
targets whose expression are affected in En1Cre/+;Foxa1flox/flox;Foxa2flox/flox mutant 
embryos together with Foxa2 and Otx2 on FANTOM and searched for possible 
Figure 3-20: qPCR expression analysis of Foxa2 regulated target genes that may be 
coregulated by Otx2.in ventral midbrains of En1Cre/+;Otx2flox/flox mice at E10.5. (A-C) Of 
the 24 genes regulated by Foxa2, that contains an Otx2 DNA binding motif in their 
candidate regulatory regions, 10 are differentially expressed within these mutants and are 
likely to require an Otx2 input for their proper expression. In this case Lmx1a is used as 
control (Omodei et al., 2008)  * Fold change between mutant and wild type littermate 
(Control) is statistically significant with p-value<0.05. 
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interactions. Interestingly, other than Foxa2 interacting with Otx2 we see that Tle1 is a 
possible cofactor (Figure 3-21). Tle1 is part of the Groucho family of transcriptional 
repressors that play key roles in developmental processes (Santisteban et al., 2010). It has 
previously been shown in liver cells that Foxa proteins recruit Tle cofactors to the site of 
action and repress gene expression (Sekiya and Zaret, 2007). We therefore hypothesize 
that Foxa2 may act through Tle1 to repress the alternative cell fates. In addition, Foxa2 
interacts with Otx2 to induce the DA neuronal cell fate. These predictions also suggest 
that Foxa2 and Otx2 may be involved in a larger complex including Mitf, a known gene 
activator involved in melanocyte development, proliferation and survival (Kumasaka et 
al., 2005). Hence, Mitf may play similar roles in the mDA system during specification. 
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3.1.2.10 Identification of Lmx1a and Lmx1b regulatory elements 
Analysis of the phenotype of Lmx1a and Lmx1b double mutant embryos 
demonstrated overlapping essential reveals their roles in the specification and 
proliferation of mDA progenitors, and ensure their proper differentiation (Yan, 2008). In 
an attempt to further characterize the transcriptional regulators that act upstream of 
Lmx1a and Lmx1b in the midbrain we used an in vivo reporter assay to identify the cis-
acting sequences that regulate Lmx1a/b gene expression (Simmons, 2001). Two well-
conserved Foxa2-bound genomic regions identified from the ChIP-Seq data in both gene 
loci were used for independent ChIP-qPCR analysis (Figure 3-22). 
 
Figure 3-21: Physical interaction identified, using FANTOM4, of Foxa2 regulated 
transcription factors.   
In purple, Circles connected by lines indicate the occurrence of physical interactions 
between the two factors sharing each end of the line. Black arrows indicate positive 
regulation of expression. Black Arrows leading from factors other than Foxa2 are 
predicted by FANTOM4. Foxa2 and Otx2 possibly interact and cooperate to induce 
the DA neuronal fate. The Tle1/Foxa1/2 interaction is possibly required for the 
repression of alternative fates.  
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All four regions enriched for Foxa2 binding and confirmed the ChIP-Seq peaks 
identified for them. To further validate these regions in vivo, they were cloned in a LacZ 
reporter plasmid and injected into fertilized mouse embryos to assess their enhancer 
activity by X-gal staining at E10.5. Interestingly, three out of the four regions exhibited 
enhancer activity driving expression of the lacZ reporter gene to regions of the ventral 
CNS in transgenic mice (Figure 3-23). Both Lmx1a genomic regions CR1, and CR2 
activated LacZ expression in transgenic embryos. CR1 is 522 bp long and CR2 is 446 bp. 
Lmx1a CR1 gave reporter expression throughout the ventral neural tube that mimicked 
the Foxa2 expression pattern, where as Lmx1a CR2 gave an expression pattern similar to 
rostral domain of the Lmx1a endogenous expression pattern, i.e. in the caudal forebrain 
and anterior midbrain (Figure 3-23A and C). Identifying two enhancers for Lmx1a 
suggests the requirement of multiple signaling inputs to multiple cis-regulatory elements 
for the proper regional expression of this gene. One of the two regions tested for Lmx1b 
gave reporter expression (Fgure 3-23E). This region was named Lmx1b CR1 and is 206 
bp long. The LacZ expression pattern mimics very well the expression of Lmx1b in the 
ventral neural tube, and the future auditory neural tissue (Yan, 2008; Guo et al., 2007). 
Coronal sections through the midbrains of the embryos that gave restricted expression 
Figure 3-22 ChIP-qPCR experiments performed using chromatin from E12.5 mouse ventral 
midbrain using Foxa2 specific antiserum. 
 Lmx1a/b conserved regions are enriched for Foxa2 binding compared to negative control 
regions (-ve1, -ve2). The conserved region in the Corin gene locus is used as positive control. 
Error bars represent SEM. Each ChIP was performed on chromatin samples from three 
biological replicates. * Enrichment of Foxa2 bound regions over the negative region in the 
ChIP samples was statistically significant (P < 0.05). 
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patterns in the ventral midbrain indicate that LacZ expression was restricted to 
endogenous domains of Lmx1a and Lmx1b expression in the ventral midbrain (Figure 3-
25, 3-26). 
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Consensus binding sites for Foxa2 were identified in all enhancers supporting the 
view that Foxa2-dependent mechanisms exist to activate Lmx1a/b gene expression in the 
midbrain floor plate. Luciferase assays were carried out for all three enhancers to 
establish if Foxa2 exerts an input on the regulatory activity of these enhancers in P19 
cells. Co-transfection of Foxa2 with the Lmx1a CR1 and CR2 luciferase constructs 
shows a significant but not very high fold change of luciferase activity over the single 
transfections. This may be due to the presence of another co-activator since these 
enhancers already posses positive regulatory activity when compared to the empty 
luciferase vector. The presence of a repressor of Foxa2 activity may be possible, not 
allowing optimum Foxa2 regulation of these enhancers. Co-transfection of Foxa2 with 
the Lmx1b CR1 luciferase construct shows a significant and high fold change suggesting 
a strong Foxa2 input in the regulation of this enhancer. From these results we chose to 
mutate the Foxa2 binding site (Figure 3-24 B) found within the Lmx1b CR1 and perform 
the in vivo LacZ reporter assay. The LacZ expression of the mutated construct was 
Figure 3-23:LacZ reporter expression driven by the genomic regions identified to be 
bound by Foxa2 within the Lmx1a and Lmx1b gene loci.  
(A-B) Lmx1a CR1 has a broad expression pattern very similar to the Foxa2 expression 
pattern is the same developmental stage. 2/2 transgenics gave the same expression 
pattern (C-D) Lmx1a CR2 drives expression in a restricted domain within the rostral 
midbrain and most caudal forebrain regions similar to the Lmx1a expression pattern in 
those regions. 1/1 transgenic embryo gave this expression pattern (E-F) Lmx1b CR1 is 
sufficient to drive expression in the Lmx1b positive domains in the midbrain. 3/4 
transgenic embryos gave this expression pattern. (B, D, and F are whole mount ISH of 
Foxa2, Lmx1a and Lmx1b respectively. Modified from Epstein et al, 1996, and Yan, 
2008) 
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generally weaker and the midbrain LacZ expression was reduced to a large extent. These 
results clearly show the requirement of the Foxa2 site for the proper regulation of this 
enhancer. 
 
 
 
 
 
 
Figure 3-24: The Foxa2 DNA binding motif within the Lmx1b CR1 is required for 
driving expression to the floor plate of the midbrain and in caudal CNS regions. 
 (A) Wild type expression pattern. Red box indicates the Foxa2 DNA binding motif. 
(B) Foxa2 motif mutated construct drives very weak expression and the majority of 
the midbrain specific expression was lost. 2/2 transgenic embryos gave the same 
expression pattern. 
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 Figure 3-25: Coronal sections through the midbrain of Lmx1a CR2 
transgenic mouse at E10.5. 
 LacZ expression pattern is restricted to the floor plate in the rostral 
midbrain. It is unclear whether LacZ expression is restricted to the 
floor plate or is also expressed in more dorsal progenitors in the 
anteriormost regions based on these sections, however the 
anteriormost expression mimics Lmx1a expression in wild-type 
embryos (Fig. 3-23D). 
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Figure 3-26: Coronal sections through the midbrain of the Lmx1b CR1 
transgenic mouse at E10.5.  
Expression pattern is restricted to the floor plate region throughout the A-P 
axis, similar to Lmx1b expression in wild-type embryos at this stage. 
 113 
3.1.3 Identification and characterization of Foxa2 binding events in vivo 
In the next chapters we present results generated from Foxa2 ChIP-Seq experiments 
performed on in vivo E12.5 and E14.5 ventral midbrain dissected tissue. For illustrative 
reasons many of the regions identified as bound by Foxa2 will be identified by black 
blocks rather than the peaks you have been shown up to this point. 
 
3.1.3.1 Foxa2 ChIP-seq performed on E12.5 and E14.5 ventral midbrain tissue 
To identify genes regulated by Foxa2 that are involved in differentiation we chose 
a different approach than the previous experiment. We dissected ventral midbrain tissue 
at  time points where differentiation is actively taking place. The proneural gene Neurg2 
and the orphan nuclear receptor Nurr1, expressed in immature and mature neurons, are 
key markers of this process. At E12.5 the ventral midbrain stains for Neurog2 in a salt 
and pepper pattern and an overlap with Nurr1 can clearly be observed (Ferri et al., 2007). 
Given this pattern of expression, E12.5 is an appropriate time point to model early 
differentiation and study the role of Foxa2 in this process. 
In addition of investigating the role of Foxa2 function in early differentiation we 
wanted to complement the study with an additional investigation of the role of Foxa2 in 
late differentiation of mDA neurons. The time point chosen for this study is E14.5 where 
neurogenesis has largely ceased and only mature neurons can be identified by staining for 
Nurr1 and TH, where most if not all Nurr1+ cells stain for TH, indicating that not many 
immature neurons are present.  
Figure 3-27 indicates the ventral midbrain regions dissected and harvested for the 
ChIP-seq analysis. This procedure was performed for both E12 and E14 ChIP-Seq assays. 
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Figure 3-27:Schematic of E14.5 midbrain dissection limits defining the mDA 
domain.  
Line 1 indicates the dorsal limit. Lines 2 and 3 indicate the harvested area, 
including the mDA domain used for the ChIP experiments. (Modified from Jacobs, 
2009) 
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The quality of the in vivo data sets was assessed according to known and newly 
discovered positive controls from the in vitro analysis. Enhancers known to be bound by 
Foxa2, such as the Shh brain enhancer, the Lmx1a CR2, Lmx1b CR1 and the Aadc 
neuronal promoter, were detected by our in vivo ChIP-Seq assays, and all these bound 
regions had a FDR well under 5% (Figure 3-29). For the purpose of these studies we 
assigned 5% FDR as the cut off point for the regions to be included in the analysis.  
Furthermore, the Foxa2 motif was enriched in both E12 and E14 ChIP-seq data sets 
(Figure 3-28B-C). We also observed 1407 (20%) regions in common between the in vitro 
and E12.5 data sets, and 1717 (25%) regions were in common between the E12 and E14 
data sets. Of these regions over 40% were in common with the in vitro data set, further 
confirming the high quality of the data in all three ChIP-seq experiments.  
. 
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Figure 3-28:. (A) Schematic of the Shh gene locus extracted from the UCSC genome browser. 
Foxa2 peaks can be observed in the Shh floor plate enhancer region in all three data sets. (B) De 
novo motif enriched in E12 and E14 ChIP-seq data sets identified using MEME search engine. 
The motif is identical to the Foxa2 DNA binding motif. 
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Figure 3-29: Schematic of the genomic regions bound by Foxa2 in all three data sets.  
(A-C) Foxa2 peaks can be observed in the gene loci of Corin, Lmx1a, and Lmx1b previously 
identified in the in vitro data set. (D) Foxa2 peaks can be observed in the AADC locus in all 
three data sets. At E12 a Foxa2 peak is observed in the AADC neuronal promoter described 
by (Aguanno et al., 1995). (Each black block indicates the area covered by the detected peak) 
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3.1.3.2 Characterization of ChIP-Seq peaks identified using E12.5 ventral 
midbrain tissue 
From the E12.5 ChIP-seq analysis we identified 7008 high confidence peaks. 
Interestingly, 54% of peaks were located within an annotated gene region. Only 18% of 
the peaks were located within 2 kb upstream or downstream of the TSS of annotated 
genes, while 34% of the peaks were located within 10 kb of the TSS (Figure 3-30). Out 
of peaks overlapping genes 24% were localized within the first intron (Figure 3-31 A). 
We also observed that over 30% of all peaks were more than 100 kb from the closest 
down stream gene (Figure 3-31 B). Surprisingly, 45% overlapped conserved genomic 
regions, identical to the in vitro data, suggesting that Foxa2 binding to conserved 
sequences is a key characteristic of its binding to the genome. Similar to the in vitro data 
Foxa2-binding sites are observed at a range of locations across the mouse genome.  
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Figure 3-30: Percentage of binding sites located at various distances from TSS. 
Recruitment at distal regions from the TSS is a general characteristic of Foxa2 
genomic recruitment 
Figure 3-31. (A) Distribution of peaks within genes. Majority of peaks are distributed within 
intronic regions with 24% identified within the first intron. (B) Distribution of the peaks from the 
nearest downstream gene. Most of the peaks are found between 10 and 100 kb away from the 
nearest downstream gene. 
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3.1.3.3 Characterization of ChIP-seq peaks identified using E14.5 ventral midbrain 
tissue 
CHIP-seq performed on E14.5 ventral midbrain tissue identified 8346 high 
confidence peaks. Of these peaks 57.5% overlapped a gene region. Peaks identified 
within 2kb of the TSS of annotated genes represent 21% of the total number of peaks, 
and 38% were located within 10 kb (Figure 3-32). 20% of peaks within genes were 
located within the first intronic region (Figure 3-33 A). Around 30% of the peaks were 
over 100kb away from the closest downstream gene (Figure 3-33 B). Out of all peaks 
41% overlapped with conserved genomic regions further confirming Foxa2 binding to 
conserved sequences as a key characteristic. 
 
 
  
Figure 3-32: Percentage of binding sites located at various distances from TSS. 
Recruitment at distal regions from the TSS is a general characteristic of Foxa2 
genomic recruitment. An increase in recruitment of Foxa2 closer to TSS of 
annotated genes is observed. 
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Figure 3-33: (A) Distribution of peaks within genes. Majority of peaks are distributed within 
intronic regions with 2o% identified within the first intron. A reduction compared to the other two 
data sets. (B) Distribution of the peaks from the nearest downstream gene. Most of the peaks are 
found between 10 and 100 kb away from the nearest downstream gene. 
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3.1.3.4 Overlap of ChIP-Seq lists with microarray time course expression assays  
 
To identify functionally relevant genes, we chose to overlap the Foxa2-bound targets 
with expression profiling data of floor plate regions of the midbrain where the mDA cells 
reside. In the lab, a former postdoctoral fellow dissected midbrain floor plate regions 
from E10.5, E11.5, E12.5 and E14.5 embryos and analyzed the expression profile of 
these cells by microarray experiments using Illumina MouseRef-8 v 2.0 expression 
beadchip platforms. These expression data was then analyzed using Gene Spring (Agilent 
technologies) to study the temporal dynamics of gene expression in this tissue (Figure 3-
35, 3-36). We identified 5549 genes that were differentially expressed (DE) between the 
time points described. Of these genes 24% mapped with at least one peak from the in 
vitro ChIP-seq data set. Similarly, 22% of DE genes mapped with peaks from the E12 
ChIP-seq data set, and 26% mapped with the E14 ChIP-seq data set. Interestingly, the 
distribution of the Foxa2 peaks from the TSS of the DE genes indicate a 10% increase of 
peaks identified within 2kb of the TSS when comparing the in vitro ChIP-seq data with 
the E12.5 ChIP-seq data, and a 15% increase was observed when comparing the in vitro 
data with the E14.5 data set (Figure 3-34). This observation is not surprising since a 
similar distribution can be observed on the genome wide level as well. This data suggests 
that Foxa2 binding shifts slightly closer to promoter regions during differentiation of 
mDA neurons. This is comparable with adult liver genome wide studies of Foxa2, where 
many binding events can be identified close to the TSS, unfortunately these studies did 
not compare different developmental stages (Wederell et al., 2008). 
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3.1.3.5 Foxa2 binding profile of peaks associated with early and late onset genes  
We next decided to look at the distribution of Foxa2 binding sites of genes with 
specific expression trends. DE genes from the in vivo microarray time course experiment 
were clustered into 12 sub-clusters according to Pearson correlation with P-value < 0.001. 
This allowed us to choose groups of genes with specific expression patterns of biological 
importance for the development of midbrain DA neurons. Two groups of genes were 
chosen according to their co-clustering with known progenitor and mature DA neuronal 
markers. A group of 342 genes that included progenitor markers such as Lmx1a, Foxa2, 
Slit2, and Corin are described as early onset genes, and the group of 1605 genes that 
includes mature neuronal markers such as Th, Pitx3, and Ddc are described as late onset 
genes (Figures 3-35, 3-36).  
Figure 3-34:Comparison of genome wide Foxa2 binding profile with DE candidate targets. 
Distribution of peaks within 2 kb of TSS of all annotated genes (Genomic binding) and of DE 
targets reveals that the shift of Foxa2 binding towards the TSS of genes in the in vivo data sets 
is a general characteristic of Foxa2 genomic distribution. 
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Figure 3-35: Gene expression time course assay of in vivo early onset 
genes (E10-E14). Genes presented: Foxa2, Lmx1a, Slit2, Corin, Shh, and 
Bmp7. 
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For the purpose of this study we carried out the analysis of peaks from the in vivo 
ChIP-seq data sets that mapped with early and late onset genes. Of the early onset genes 
121 overlapped with the E12 ChIP-seq data set and 132 with the E14 ChIP-seq data set. 
Also, 489 of the late onset genes overlapped with the E12 data set and 588 genes 
overlapped with the E14 data set. The distribution of the Foxa2 binding sites from the 
TSS of these genes is similar to the genome wide observed distribution  (Table 2 and 3).  
Figure 3-36: Gene expression time course assay of in vivo late onset 
genes (E10-E14). Genes presented: TH, Pitx3, and Ddc. 
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Table 2: Distribution of peaks identified in all three data sets (E12, E14, in 
vitro) from the TSS of early and late onset genes expressed in vivo. The 
majority of the peaks can be identified within 100 kb of the TSS of annotated 
genes. An increase can be detected in the number of peaks within 2kb of the 
TSS between in vitro and in vivo ChIP-seq assays. 
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Table 3: Distribution of peaks identified in all three data sets (E12, E14, in vitro) from the 
TSS of all annotated genes. The majority of the peaks can be identified within 100 kb of the 
TSS of annotated genes. An increase can be detected in the number of peaks within 2kb of the 
TSS between in vitro and in vivo ChIP-seq assays. 
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3.1.3.6 GO term analysis reflects Foxa2 possible functions during mDA neuron 
differentiation  
In order to establish which biological processes may be regulated by Foxa2 at E12 
and E14 involved in midbrain DA neuronal development, GO term analysis was 
performed on the early and late onset genes that overlapped with the E12 ChIP-seq data 
set, and on the late onset genes that overlapped with the E14 ChIP-seq data set. As 
expected, early onset genes bound by Foxa2 at E12 when neurogenesis is actively taking 
place are enriched for terms involved in neuron fate commitment, regulation of 
neurogenesis, and axon guidance (Figure 3-37). It was interesting to observe in the late 
onset genes bound at E12 to be enriched for terms involved in regulation of synaptic 
transmission and neuron projection development, processes which are usually active at 
late stages of neuronal development, suggesting the involvement of Foxa2 in later 
neuronal processes during differentiation (Figure 3-38) (Cowan M W et al., 1997).  
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Figure 3-37: Gene ontology (GO) categories showing the most enriched biological processes of 
early onset candidate targets identified from the E12 ChIP-seq data set. 
 All categories displayed are of p-value<0.001 and are sorted according to fold change of the 
number of genes in each biological process in the experiment list over the reference list (whole 
genome). 
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Figure 3-38:Gene ontology (GO) categories showing the most enriched biological processes of 
late onset candidate targets identified from the E12 ChIP-seq data set. 
 All categories displayed are of p-value<0.001 and are sorted according to fold change of the 
number of genes in each biological process in the experiment list over the reference list (whole 
genome). 
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Late onset genes bound at E14.5 by Foxa2 reveal terms enriched for ATP hydrolysis 
coupled with proton transport, dendrite morphogenesis, and regulation of neuronal 
synaptic plasticity (3-40). This suggests later roles of Foxa2 in the regulation of energy 
utilization in the cell coupled with late neuron differentiation processes. Since many of 
these genes bound at E14.5 are also bound and may be regulated at E12, we perform the 
GO term analysis on genes uniquely bound at E14.5 (Figure 3-42). The regions bound 
only at E14.5 were obtained by subtracting from the E14.5 ChIP-Seq candidate gene list 
all the candidate target genes bound at E12. This should produce a list enriched in 
candidate genes uniquely bound at E14.5. To further confirm this, independent ChIP-
qPCR assays with Foxa2 antiserum were performed on regions uniquely bound at E14.5, 
E12.5 and on regions shared at both stages (Figure 3-39). The results suggest that the 
E14.5 unique Foxa2 bound gene list is truly enriched with regions only bound at E14.5 
and the genes mapped to these regions are likely not bound and consequently not 
regulated at E12.5. Interestingly, the GO terms enriched for Foxa2 candidate targets 
unique for the E14.5 list are involved in transmission of a nerve impulse (Figure 3-41). 
This result suggests the possible requirement of Foxa2 at E14.5 for the late functions of a 
neuron in transmitting its signals.  
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Figure 3-39 ChIP-qPCR assays performed on chromatin from E12.5 and E14.5 
mouse ventral midbrain using Foxa2 specific antiserum. (A) Foxa2 binding to  
regions unique to the E12.5 ChIP-seq list. (B) Foxa2 binding to regions unique to 
the E14.5 ChIP-Seq list. (C) Foxa2 binding to regions shared between both the 
E12.5 and E14.5 ChIP-Seq lists. Error bars represent SEM. Each ChIP was 
performed on chromatin samples from three biological replicates. * Enrichment of 
Foxa2 bound regions over the negative region in the ChIP samples was statistically 
significant (P < 0.05). 
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Figure 3-40:Gene ontology (GO) categories showing the most enriched 
biological processes of late onset candidate targets identified from the E14 
ChIP-seq data set.  
All categories displayed are of p-value<0.001 and are sorted according to fold 
change of the number of genes in each biological process in the experiment list 
over the reference list (whole genome). 
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Figure 3-41: Gene ontology (GO) categories showing the most enriched biological 
processes of late onset candidate targets unique to the E14 ChIP-seq data set.  
All categories displayed are of p-value<0.001 and are sorted according to fold 
change of the number of genes in each biological process in the experiment list over 
the reference list (whole genome). 
 137 
3.1.3.7 Validation of late onset gene targets in Nestin-Cre Foxa1/2 flox mutant mice 
For validation purposes of the functional relevance of Foxa2 binding to its target 
genes, 30 late onset genes, including transcription factors, bound by Foxa2 at both E12 
and E14 were selected for testing in the NestinCre/+;Foxa1flox/flox;Foxa2flox/flox conditional 
mutant mouse model. In this model the midbrain DA progenitors are specified but do not 
fully differentiate (Kele et al., 2006). Thus, the main genes that are affected in these 
mutants are late onset genes that are likely activated during differentiation. From RT-
qPCR expression assays we can observe that 50% of the genes analyzed are affected in 
the mutants compared to their wild type littermates (Figure 3-42). This data provides 
further confidence for the quality of the lists for predicting Foxa2 regulated genes.  
 
 
 
 
 
Figure 3-42: RT-qPCR validation of Foxa2 targets in ventral midbrain tissue of 
NestinCre/+;Foxa1flox/flox;Foxa2flox/flox mice at E12.5. Expression analysis by qPCR of 
candidate target transcription factors, and genes involved in other functions. * Fold change 
between mutant and wild type littermate (Control) is statistically significant with p-
value<0.05. 
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3.1.3.8 Prediction of physical interaction of transcription factors regulated by 
Foxa2 in vivo 
From the previous assay we identified late onset transcription factors regulated by 
Foxa2 and bound at both stages E12 and E14. It is very interesting to discover 
transcription factors that require Foxa2 input at multiple developmental time points. This 
suggests that these factors may be of much importance for the regulation of 
differentiation. To further classify these transcription factors, we used FANTOM 4 to 
identify any possible interactions these transcription factors may have between them 
(Figure 3-43). Notably, two interaction clusters were identified. The first involves the 
interaction of nuclear receptors Esrrb, Ncoa2 (Src-2), and Rora. It has previously been 
shown that Foxa2 interacts with nuclear receptors to induce its target genes (Carroll et al., 
2005). The second cluster identified involves the interaction of nuclear factors Nfib and 
Nfic. These factors are very interesting since they seem to play important roles in 
regulating neurogenesis (Kumbasar et al., 2009). Also the BHLH-PAS member Arnt2 is 
predicted to be upstream of these nuclear factors and may be involved in mDA neuron 
development in mouse since it has such a role in Zebrafish DA neuron development 
(Löhr et al., 2009). 
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3.1.3.9 Close correlation of Foxa2 binding events with Gli1 bound regions 
The zinc finger transcription regulators Gli1-3 mediate Shh morphogen activity 
through binding to their consensus sequence and controlling the transcription of their 
target genes (Hooper and Scott, 2005). A recent ChIP-on-chip study has identified 
multiple genomic regions bound by Gli1 (Vokes et al., 2007), where many of the 
associated transcripts are components of Shh signaling. Also, many of these regions have 
already been published as enhancers regulated by Gli activity (Sasaki, 1997; Agren, 
Figure 3-43: Physical interaction predicted by FANTOM4, of Foxa2 regulated 
transcription factors.  
 In purple, Circles connected by lines indicate the occurrence of physical interactions 
between the two factors sharing each end of the line. Black arrows indicate positive 
regulation of expression. Black Arrows leading from factors other than Foxa2 are 
predicted by FANTOM4. Nuclear receptors (Essrb, Rora, and Ncoa2) regulated by 
Foxa2 possibly interact and cooperate to induce downstream target genes.  
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2004; Hallikas, 2006; Dai, 1999; Santagati, 2003). Notably, Foxa2 bound regions 
identified in our ChIP-seq data sets are observed within the Gli1 ChIP-on-chip peaks 
from the mentioned study, suggesting a tight regulatory loop between Foxa2 and Shh 
signaling (Table 4). Further more, Foxa2 binding events have been identified in both Gli1 
and Gli2 loci (Element1-5), whereas Gli1 only regulates its own enhancer (Figure 3-44). 
This data is supported by genetic analysis of the Wnt1Cre/+;Foxa2flox/flox mouse embryos 
performed by a former student in the lab (Appendix D: Figure 4-13). It was observed that 
Foxa2 acts by repressing Gli1 and Gli2 as well as Ptch1 in the mDA system. Together 
with results from our ChIP-seq data we suggest that Foxa2 repression of these genes is 
direct. 
 
 
 
 
 
 
Table 4:Foxa2 binding to genomic regions identified in a Gli1 ChIP-on-
chip study (Vokes et al., 2007). 
 Regions are described as base pairs away from the TSS. The Foxa2 ChIP-
Seq data sets that present the binding events in each case are mentioned. 
Foxa2 is shown to bind directly to enhancer regions regulating components 
of the Shh signaling pathway. 
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Figure 3-44: Occupancy of Gli2 gene conserved elements by Foxa2. (A) Schematic diagram of 
the Gli2 locus indicating peaks generated by Foxa2 in vitro ChIP-Seq experiment (E1-E5). (B) 
Foxa2 binding sites (in yellow) identified by the Jaspar database and their conservation.(C) 
ChIP experiments using chromatin from E12.5 ventral midbrain tissue validating the ChIP-
Seq results using Foxa2 anti serum or anti-IgG antibody (M: Mock IP). Error bars represent 
SEM. Each ChIP was performed on chromatin samples from three biological replicates, and 
enrichment of all Gli2 elements in the Foxa2 ChIP samples compared with the mock ChIP 
was statistically significant (P < 0.05). 
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3.1.3.10 Differential binding of Foxa2 on promoters driving the expression of the 
DA synthesis enzymes TH and AADC 
The possible role of Foxa2 in inducing TH and AADC (also known as Ddc) has 
previously been described (Bae et al., 2009; Raynal et al., 1998 2006). Interestingly, 
AADC expression precedes that of TH in midbrain DA neurons. AADC can already be 
detected in these cells at E10.5 whereas the first TH+ cells can be detected at E11.5 
(Castelo-Branco and Arenas, 2006; Mavromatakis, 2006). Identifying the mechanism 
responsible for this differential expression of TH and AADC will provide useful 
information regarding the control of the developmental timing of gene expression. Lee et 
al, have described the efficient binding of Foxa2 to the TH promoter through ChIP assays 
only in the presence of Nurr1, suggesting that Nurr1 acts as a recruitment factor for 
Foxa2 on this region. The authors have also identified the Foxa2 DNA binding sequence 
within the TH promoter that is required for the Foxa2 specific induction of luciferase 
activity. Raynal et al. identified the Foxa2 DNA binding motif within the AADC 
neuronal promoter and have shown Foxa2 binding to this region through electrophoretic 
mobility gel shift assays. Luciferase assays of AADC neuronal promoter in the context of 
P19 cells show a Foxa2 specific induction that further strengthens the argument of the 
presence of a Foxa2 input (Table 5). 
We performed ChIP assays and quantified with qPCR to assess Foxa2 binding to 
these regions at both stages E10.5 and E12.5 of ventral midbrain (VM) development 
(Figure 3-46). We observe clear Foxa2 binding to the AADC neuronal promoter at E10.5 
but this is not the case for the TH promoter at this stage. Foxa2 binding is observed at 
both promoters in ChIP assays performed on E12.5 VM (Figure 3-46). This result can be 
partially explained by comparing the Foxa2 DNA binding motifs of both promoters. The 
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Foxa2 motif in the AADC neuronal promoter is identical to the known Foxa2 motif (high 
affinity) providing the possibility of strong protein/DNA interaction (Figure 3-45). 
Whereas the motif identified in the TH promoter by Lee et al. is not a perfect match for 
the Foxa2 DNA binding motif (low affinity), indicating that Foxa2 may not interact 
strongly at this sequence. These results suggest that Foxa2 requires another transcription 
factor or higher concentration of Foxa2 are required for binding to the low affinity Foxa2 
motif in the TH promoter.  
 
 
 
 
Figure 3-45: Comparison of the Foxa2 DNA binding domain defined 
by the Jaspar base with Foxa2 bound sequences in the AADC 
neuronal promoter and the TH promoter. 
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Figure 3-46: ChIP-qPCR assays performed on chromatin from E10.5 and E12.5 mouse ventral 
midbrain using Foxa2 specific antiserum. (A) Foxa2 binding to promoter regions of the AADC 
neuronal promoter and the TH promoter at E10.5 (B) Foxa2 binding to promoter regions of 
the AADC neuronal promoter and the TH promoter at E12.5. Foxa2 binds to both promoter 
regions only at E12.5 compared to binding only to the AADC promoter at E10.5. Error bars 
represent SEM. Each ChIP was performed on chromatin samples from three biological 
replicates. * Enrichment of Foxa2 bound regions over the negative region in the ChIP samples 
was statistically significant (P < 0.05). 
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3.1.3.11 Luciferase enhancer analysis of Foxa2 bound regions suggests the 
requirement of co-factors 
To further analyze the mechanisms governing the regulation of Foxa2 function we 
performed luciferase enhancer reporter assays on genomic regions bound by Foxa2 that 
also contain, Lmx1a, Otx2 and/or Nurr1 binding motifs, since genetic data predicts that 
these factors cooperate with Foxa2 to perform their function (Yan, 2008; Perez-Balaguer 
et al., 2009; Lee et al., 2010; Rascle et al., 2008; Uniprobe, Jaspar database). These 
regions were divided into two groups according to the transcripts they are predicted to 
regulate, progenitor markers (First nine) and mature neuron markers (Last 4) (Table). The 
genomic regions of mature neuron markers are tested for Foxa2, Lmx1a and Nurr1 
induction, whereas the progenitor markers are tested for Foxa2, Lmx1a and Otx2 
induction. Interestingly, Foxa2-mediated effect was observed on 70% (9/13) of the 
regions suggesting Foxa2 may require other factors to induce a subgroup of its targets. 
Otx2 can induce only 3 of the nine regions it was tested on and only one region (Bmp7) 
show cooperative interaction with Foxa2 (Table 5). This may imply that not many targets 
co-regulated by Foxa2 and Otx2 were tested, or that Otx2 interacts with Foxa2 to induce 
a very specific subset of genes. Surprisingly, Lmx1a had an effect on the enhancer 
activity of 90% of the regions (9/10) tested. Lmx1a and Foxa2 had a synergistic effect on 
the enhancer activity of four of these regions. Furthermore, Foxa2 and Lmx1a together 
but neither of the single factors alone stimulated the enhancer activity of genomic regions 
of Slit2 and Pitx3 (Figure 3-47). These results strongly suggest that Foxa2 and Lmx1a 
cooperate in inducing this subset of regulatory elements. Out of the four regions tested 
with Nurr1, three show combinatorial effect with Foxa2. This indicates a possible 
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interaction of Foxa2 with Nurr1 to affect these regulatory elements. Further studies need 
to be performed to dissect these interactions.  
 
 
 
 
 
 
 
Figure 3-47: Synergistic relationship of Foxa2 with Lmx1a and Nurr1. 
(A) Synergistic activation of the Slit2 enhancer by Foxa2 and Lmx1a. (B) 
Synergistic activation of the Pitx3 enhancer by Foxa2 and Lmx1a or Nurr1. 
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Table 5: Summary of the luciferase assays performed on regions bound by Foxa2 in vitro and in 
vivo. F: Foxa2, L: Lmx1a, O: Otx2, N: Nurr1, F+L: Cotransfection of Foxa2 and Lmx1a, F+O: 
Cotransfection of Foxa2 and Otx2, F+N: Cotransfection of Foxa2 and Nurr1. +: Significant Fold 
change of cotransfections of Luciferase construct with transcription factors compared to 
transfection of the Luciferase construct alone but does not illustrate combinatorial effect. 
(Inductive effect ). ++: Significant fold change of cotransfections of the Luciferase constructs 
with transcription factors compared to transfection of the Luciferase construct alone and also 
illustrates synergistic effect. (Inductive effect). - : Significant fold change of cotransfections of 
Luciferase constructs with transcription factors compared to transfection of the Luciferase 
construct alone but does not illustrate synergistic effect. (Repressive effect). -- : Significant fold 
change of cotransfections of Luciferase constructs with transcription factors compared to 
transfection of the Luciferase construct alone and also illustrates synergistic effect. (Repressive 
effect). Red dot indicates no effect.  
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3.1.3.12 Corin and Slit2 are affected in the Shh-Cre Lmx1a (dreher)/Lmx1b Flox 
double mutant mice  
We have shown previously that Foxa2 binds to genomic regions close to the TSS of 
many genes expressed in the ventral midbrain. Corin and Slit2 show a restricted 
expression within the mDA progenitor domain. The luciferase assays performed on 
genomic regions close to the TSS of these genes indicates that both Foxa2 and Lmx1a 
have an input in regulating these regions. Expression analysis of these genes through ISH 
indicates that these genes are lost in the ShhCre/+ Lmx1adrdr/Lmx1bfloxflox mutant mouse 
embryos compared to their wild type littermates (Figure 3-49). Moreover, ChIP-qPCR 
assays with Lmx1b antiserum suggest the direct binding of Lmx1b to the Corin and Slit2 
genomic regions identified from the Foxa2 ChIP-Seq analysis (Figure 3-48). This result 
confirms further the requirement of both Foxa2 and Lmx1a for the proper expression of 
these genes and the mechanism by which this occurs is through binding and regulating 
the identified Corin and Slit2 enhancers. In vivo LacZ reporter analysis of these 
enhancers is required to further confirm this observation.  
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Figure 3-48: ChIP-qPCR assays performed on chromatin from E12.5 mouse ventral midbrain 
using Lmx1b specific antiserum. Lmx1b binding to Enhancer regions close to the Corin ans 
Slit2 TSS. Wnt1 promoter region was used as positive control (Chung et al., 2009). Error bars 
represent SEM. Each ChIP was performed on chromatin samples from three biological 
replicates. * Enrichment of Lmx1b bound regions over the negative region in the ChIP 
samples was statistically significant (P < 0.05).  
Figure 3-48: Foxa2 targets Corin, and Slit2 are affected 
in the ShhCre/+ Lmx1adrdr/Lmx1bfloxflox mouse embryos.  
Slit2 and Corin are lost in these mutants indicating that 
Lmx1a and lmx1b are required for their proper 
expression. (Kind contribution by Dr. Martin Levesque) 
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4. Discussion 
 
Degeneration of midbrain DA neurons is observed at the onset of Parkinson’s 
disease. The detailed study of the transcriptional network involved in the development of 
these neurons will assist in future treatment of this disease. Genetic data for the Forkhead 
transcription factor Foxa2 has shown it to play an important role in the development of 
midbrain DA. The recent advances in microarray and sequencing technologies have made 
it possible to map the genome wide recruitment sites of transcription factors in living 
cells. This has allowed the identification of gene regulatory circuitry associated with 
developmental processes. This thesis presents genome wide DNA binding analysis of 
Foxa2 at two important time points of midbrain DA neuron development: Specification 
(in vitro progenitors), and differentiation (E12.5, and E14.5 ventral midbrain tissue). 
4.1 Foxa2 genomic recruitment at distant regions from the TSS 
To identify the target genes regulated by Foxa2 we applied ChIP combined with 
massively parallel sequencing. Characterizing the position of the DNA interaction sites 
relative to TSS of genes in three ChIP-Seq data sets reveals that only a small fraction of 
the Foxa2 bound regions are found within promoters, whereas the majority are found at 
large distances from annotated genes or within introns. This data is in line with previous 
ChIP-Seq studies performed on Foxa2 (Wallerman et al., 2009). A large proportion of 
these sites are conserved throughout many species suggesting that many of these regions 
are cis-regulatory elements exerting their regulation on promoters from a distance, or 
they may be regulating genes that have not yet been annotated. The wide distribution of 
the Foxa2 binding sites indicates that studies on the transcription factor activity of Foxa2 
 151 
should not be limited to promoter regions as was previously carried out in ChIP-chip 
studies since this may lead to conclusions that may not be entirely accurate (Odom et al., 
2007).  
Further experimentation is required to establish a detailed map of the distal cis-
regulatory elements that are bound and regulated by Foxa2 and identifying the effected 
transcription. This could be achieved by a large-scale enhancer reporter analysis, where 
the Foxa2 bound regions are isolated and amplified with subsequent cloning into reporter 
constructs (Luciferase or LacZ). This way producing a library containing the possible 
Foxa2 bound cis-regulatory elements. These constructs would then be used for screening 
in appropriate cell lines. Finally, sequencing of the genomic regions that pass the 
screening will reveal their genomic coordinates. Although this method will not overcome 
the difficulty of associating the cis regulatory elements with their preferred regulated 
transcripts, since any gene from any direction is a possible candidate, nonetheless, it does 
provide important data for which of the Foxa2 bound regions also demonstrate enhancer 
activity. This approach will be very difficult to perform since our data sets suggests that 
Foxa2 is bound to many thousands of distal regions that differ depending on the 
developmental stage the experiment is performed at. Also, enhancer analysis in cell lines 
is very context dependant and thus cell lines need to be chosen carefully.  
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4.2 Possible functions of Foxa2 during the specification, and 
differentiation of midbrain DA neurons revealed by GO term 
analysis 
GO term analysis has been widely used for the association of genes identified in 
large-scale experiments with known biological processes (Koudritsky and Domany, 
2008). In this study with the aid of GO term analysis we identified possible global 
functions of Foxa2 during the specification, and differentiation of midbrain DA neurons. 
Foxa2 direct targets identified at the DA progenitor stage were associated with DE genes 
during the specification process of the DA progenitor fate. We observed that Foxa2 was 
bound to genes up regulated and down regulated during this process suggesting a possible 
dual role of Foxa2 as an inhibitor and activator of gene expression. The up regulated 
genes bound by Foxa2 were highly enriched with terms involved in early neuronal 
development whereas the genes that were down regulated were highly enriched for terms 
involved in the development of alternative fates such as cardiac muscle. These data 
suggest potential roles for Foxa2 in inducing the neural fate and inhibiting the alternative 
fates. It is important to investigate the mechanisms that help Foxa2 distinguish between 
its roles as an activator or repressor. Co-factors such as Tle1 (Groucho1) have been 
shown to be recruited by Foxa2 on the regulatory elements of genes that are destined to 
be repressed (Santisteban et al., 2010). It will be very interesting to see if the same model 
applies for the repression of genes identified in our system since Tle1 is expressed and 
may perform similar roles. 
The Foxa2 target genes identified at E12.5 are enriched with terms involved in 
neural fate commitment, neuron development and neurogenesis. Finally, terms enriched 
at E14.5 indicate the subsequent roles of Foxa2 in regulating genes involved in synaptic 
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and nerve impulse transmission. These results suggest that Foxa2 may play very 
important roles during DA neuron differentiation and their mature functional aspects.  
The study of the regulatory elements controlling the expression of these genes will 
provide insightful information for the mechanisms involved in the distinct regulation of 
the developmentally early and late genes. The first step will involve the careful grouping 
of the elements according to the timing of expression of the associated genes and analysis 
of the DNA sequence for transcription factor motifs, in the attempt to identify common 
signaling inputs involved in their regulation. 
4.3 Foxa2 function regulated by co-factors 
Gene expression is controlled by regulatory elements bound by combinations of 
transcription factors. Foxa2 expression is much broader than the domain where mDA 
neurons reside and this suggests that there may be another co-factor regulating Foxa2 DA 
specific functions. Hence, the identification of co-factors that function together with 
Foxa2 in regulating DA neuron development is crucial for understanding this process. 
ChIP-seq is quickly proving to be a very efficient way to identify such cofactors for your 
gene of interest (Motallebipour et al., 2009; Wallerman et al., 2009).  
4.3.1 E-box binding proteins may cooperate with Foxa2 in early specification and 
neurogenesis of midbrain DA neurons 
 In our study we identified an E-box motif (CAGCTG) that is enriched in the in vitro 
data set. This motif is very similar to the DNA binding motifs of two basic-helix-loop-
helix transcription factors Mash1 (Ascl1), and AP-4 (Castro et al., 2006; Jung and 
Hermeking, 2009). Mash1 is usually an activator whereas AP-4 is usually an inhibitor of 
transcription (Kim et al., 2006). This motif is highly enriched in genomic regions 
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associated with genes that are up regulated in the in vitro DA progenitor model, thus 
supporting the possibility that this motif may be bound by Mash1 or another E-box 
binding protein that functions as an activator. This sequence was not enriched in the in 
vivo data sets suggesting the E-box binding co-factor may be part of an early DA 
specification transcription factor combinatorial code. 
It has recently been shown that midbrain DA neurons in Ngn2 mutant mice fail to 
develop normally mainly due to a block in generation of Nurr1+ precursors. This is 
observed by a 66% reduction in TH+ neurons at the end of the neurogenic period (E14.5) 
(Kele et al., 2006). Interestingly, Mash1 was also reduced in the DA progenitor domain 
suggesting a possible contribution to this dramatic phenotype.  Furthermore, substitution 
of Ngn2 expression Mash1 knock-in at the Ngn2 locus partially rescued the phenotype 
indicating the requirement of Ngn2 for the proper development of mDA neurons (Kele et 
al., 2006). This work also suggests redundancy between Ngn2 and Mash1 functions. This 
notion is further supported by a recent study of the Delta-like 3 (Dll3) promoter, where it 
is shown that Mash1 and Ngn2 bind to the same regulatory elements of this promoter in a 
single complex. They also indicate that Mash1 and Ngn2 interaction with the specific E-
box sequence (CACATG) may require other unknown factors (Henke et al., 2009). In our 
study, we have identified Foxa2 binding events in vivo in the Nurr1 promoter 118 bp 
upstream of the TSS (Figure 4-5). It will be very interesting to investigate if the 
Mash1/Ngn2 complex is involved in regulating the Nurr1 promoter and if Foxa2 is 
required for this function. This data would give Foxa2 a direct role in promoting the 
maturation of mDA neurons by directly inducing Nurr1. In support of this model, 
analysis of the Nestin-Cre Foxa1/2 double mutants by Ferri et al. show that the cells are 
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blocked at neurogenesis, since by E12.5, Neurog2 expression can be identified albeit 
reduced and there is a clear block in Nurr1 expression. Conversely, work performed by 
Simon Stott in the lab where he analyzed the effect of a developmentally later Cre 
recombination of Foxa1;Foxa2 flox/flox mice driven by the DAT promoter has 
demonstrated that by E14.5 there are no more TH+ cells where deletion of Foxa1;Foxa2 
has occurred with the maintenance of Nurr1 expression indicating a requirement of Foxa 
protein to maintain TH expression (Zhuang et al., 2005).  It is worth mentioning that the 
Foxa2 peaks in the Nurr1 promoter has been identified only in the E12.5 data set but not 
E14.5 where neurogenesis has ended and the expression of Ngn2 and Mash1 is 
essentially absent in the DA domain. This provides an explanation for the maintenance of 
Nurr1 expression in the DAT-Cre Foxa1/2 F/F mice since Foxa2 is not required to 
maintain its expression. Further investigation is required to confirm these interpretations. 
4.3.2 Otx2 co-regulates a subset of Foxa2 target genes 
Genetic data have shown that Otx2 and Foxa2 may directly or indirectly regulate 
common targets involved in mDA neuron differentiation such as Shh, lmx1a, and Lmx1b 
(Omodei et al., 2008 2009). In this thesis ChIP-analysis has shown that Foxa2 and Otx2 
binds to the regulatory regions of the affected genes and indicates that this regulation is 
direct. Furthermore, a large-scale mammalian two-hybrid screen predicts a Foxa2/Otx2 
interaction. In our in vitro ChIP-Seq data set, we identified an enrichment of the Otx2 
DNA binding motif, which strongly suggests that Otx2 may co-regulate a subset of Foxa2 
direct targets. In this study, the ChIP-Seq data together with analysis of loss of function 
models for Foxa2 and Otx2, we identified 11 genes that require both Otx2 and Foxa2 
inputs for their proper expression. Among these genes, the most interesting ones are 
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Ltbp1 (latent transforming growth factor beta binding protein), Tgf-β receptor 3, and 
Bmp7, which are components of Tgf-β superfamily of signaling molecules (Fuchshofer et 
al., 2009; Zhou et al., 2009). Tgf-β signaling has been previously shown to play 
important roles in mDA neuron development (Farkas et al., 2003). Moreover, Foxa2 and 
Otx2 synergistically activated the enhancer activity of the Foxa2-bound genomic region 
of BMP7 in luciferase assays. These results indicate that Otx2 may co-regulate a small 
subset of the Foxa2 direct target genes, and the Tgf-β signaling pathway may depend on 
both factors for its proper regulation.  
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Loss of function studies in mice suggests that Foxa2 together with Otx2 are required 
for the proper expression of Lmx1a. Furthermore, ChIP-qPCR analysis using Otx2 
antiserum together with luciferase assays of Lmx1a CR2 indicates a direct Otx2 input in 
regulating this enhancer.  
The regulatory input of Otx2 on Lmx1b expression is different from that of Lmx1a. 
Analysis of En1-Cre Otx2 Flox mutant mice indicates an expansion of the Lmx1b domain 
to more dorsal regions, suggesting a possible inhibitory role of Otx2, which restricts 
Lmx1b to the mDA domain (Puelles et al., 2004). Luciferase assays of the Lmx1b CR1 
support the presence of an inhibitory effect of Otx2 when co-transfected with the 
luciferase construct. Moreover, ChIP-qPCR analysis with Otx2 antiserum of the Lmx1b 
CR1 suggests that this effect is direct. Mutation analysis of the Otx2 DNA binding motif 
within these constructs is required to confirm these observations. These results indicate 
the possible presence of an Otx2/Foxa2 code for the proper specification of mDA 
neurons through the induction of Lmx1a, and restricting the expression domain of 
Lmx1b, and also possibly through modulating the Tgf-βsignaling pathway. Further 
analysis is required to confirm the extent of disruption of the Tgf-beta signaling pathway 
by evaluating the activity of smad proteins, which are the pathway downstream effectors. 
 
Figure 4-1: Model of possible Foxa2/Otx2 interaction in mDA 
development. Foxa2 and Otx2 may be required to modulate Tgf-beta 
signaling by regulating it’s components Ltbp1, Tgf-βr3, and Bmp7. 
Furthermore, Foxa2 and Otx2 are required for the induction of 
Lmx1a. 
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4.3.3 Lmx1a cooperates with Foxa2 to regulate the specification and development 
of midbrain DA neurons 
We have investigated the possibility of a Foxa2 and Lmx1a combinatorial 
relationship in regulating gene expression. Intensive genetic analysis of mutant mice have 
strongly suggested this interaction for the proper specification of midbrain DA neurons 
(Lin et al., 2009; Nakatani et al., 2010). Luciferase reporter analysis demonstrates the 
possible occurrence of a Foxa2/Lmx1a combinatorial induction of novel enhancer regions 
regulating early and late developmental genes (Table 5). Genetic data indicates that 
Foxa2 does not function independently to induce midbrain DA properties, but requires 
Lmx1a as well. Moreover, Lmx1a can induce the complete midbrain DA phenotype only 
in the Foxa2+ domains (Nakatani et al., 2010). Furthermore, data from Nakatani et al. 
have suggested that Foxa2 and Lmx1a are required for the induction of Neurog2 either 
directly by regulating its promoter or indirectly by repressing Helt, a BHLH transcription 
factor which acts mainly as a repressor. Our ChIP-Seq data has identified a Foxa2 
binding event on a conserved region very close to the known Neurog2 enhancer on the 3’ 
end of the gene (Figure 4-4). Strikingly, an Lmx1a DNA binding motif was identified 
near the predicted Foxa2 binding site (Rascle et al., 2009). Further analysis is required to 
establish if this region demonstrates enhancer activity and the presence of a 
Foxa2/Lmx1a input for its regulation. If this model is confirmed it will place Foxa2 as a 
direct regulator of Neurog2 further expanding a feed forward loop driving the DA 
progenitors towards differentiation (Figure 4-6). 
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4.4 Conclusions from of Lmx1a and Lmx1b regulatory elements 
In this study we identified the genomic regions that govern the expression pattern 
of Lmx1b and in part the expression pattern of Lmx1a. Since the Lmx1b CR1 enhancer 
was the smallest (200 bp) of the three analyzed it made it easier to identify the possible 
Foxa2 binding site by DNA mutations and subsequent LacZ reporter assays. This 
analysis demonstrated a direct role for Foxa2 in the regulation of Lmx1b expression. This 
remains to be established for the Lmx1a enhancers. 
The LacZ expression pattern of Lmx1b CR1 enhancer is restricted to the floor plate 
where mDA neurons are born. Co-labeling analysis with floor plate markers should be 
performed to confirm this finding. We are very hopeful that this enhancer will serve as a 
good tool for lineage tracing analysis and mutant analysis specific to the floor plate by 
driving Cre expression to this region. 
Furthermore, the Lmx1a CR2 enhancer seems to drive LacZ expression to the rostral 
half of the Lmx1a+ mDA progenitor domain. Co-staining of β-gal and Lmx1a will be 
performed to confirm this interpretation. It would be very interesting to identify which 
mDA neuron subpopulation this enhancer labels at later developmental stages. It has been 
proposed that subpopulation can already be identified at E12.5. This is shown by Otx2 
expression patterns where Otx2+ labels only a subset of mDA neurons at this stage (Di 
Salvio et al., 2009). Lmx1a CR2 labeling one of these Otx2+/- subpopulations will allow 
us to speculate that these cells are specified to their subpopulations very early in 
development (E10.5). Identifying the factors involved in this early specification process 
would provide novel mechanistic insights for mDA development.  
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4.5 Foxa2 roles in coordinating Shh signaling pathway 
Foxa2 is known to induce Shh expression within the notochord and floor plate 
(Echelard et al., 1993; Hynes et al., 1995). Recent papers have demonstrated that Foxa2 
can also act as a repressor of Shh downstream targets such as Nkx2.2 (Lin et al., 2009). A 
recent study in the lab of the Wnt1-Cre Foxa2-flox mutant mice by Mavromatakis, 2006 
have demonstrated that Foxa2 is involved in modulating Shh signaling by inhibiting the 
expression of its intracellular transducer, Gli2. The ChIP-Seq data indicate that this effect 
may be direct, since Foxa2 is binding on five candidate regulatory elements on the Gli2 
locus and promoter. Furthermore, these genetic studies have demonstrated that Foxa2 is 
required for the expression of Foxa1, and the repression of other Shh signaling 
components, Ptch1 and Gli1. Notably, Foxa2 binding sites were identified on the Gli1 
and Ptch1 regulatory regions, which correlated very well with the Gli1 binding sites 
identified from a Gli1 ChIP-on-chip analysis by Vokes et al. This data suggests a direct 
role of Foxa2 in controlling the expression of Shh components and downstream targets 
(Figure 4-2). 
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Figure 4-2:Foxa2 coordinates Shh signaling. (1) Foxa2 gene activity induces the transcription 
of Shh within the notochord and subsequent diffusion of the morphogenetic Shh protein 
induces the expression of genes involved in specifying the floor plate region in the overlying 
neural plate (green arrows). Gli2, which is known to mediate the primary response of Shh 
signalling, induces the expression of Foxa2 within the presumptive floor plate region. (2) 
Foxa2 protein induces the transcriptional activation of Shh and Foxa1 in this region. Foxa2 
and possibly Foxa1 are involved in the down-regulation of Gli2 gene expression from the 
ventral midline. (3) Shh signaling induces target genes such as Nkx2.2 and also induces the 
transcription of mediators of the Shh signalling cascade including Ptc, the membrane bound 
Shh receptor. Through this activation of mediators, Foxa2 gene expression is induced, 
therefore creating a positive feedback loop in which both Foxa2 and Shh maintain their gene 
expression within this midline tissue. (3) Foxa2 may directly regulate the ventral limit of 
Nkx2.2, Gli1, Gli2, and Ptc.(Modified from Mavromatakis, 2006) 
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4.6 Concluding ideas  
Gene expression patterns are mainly controlled by transcription factors (Wilson et 
al., 2009). Foxa2 has been shown to play critical roles in the specification and 
development of various tissues in mouse and C elegans  (Gaudet and Mango, 2002; Li et 
al., 2009; Santisteban et al., 2010; Xu et al., 2009). This observation suggests that Foxa2 
is involved in the regulation of gene expression patterns in a highly complex manner. 
Numerous models have been generated for the possible mechanisms of Foxa2 function. 
From our data a number of possible model mechanisms of Foxa2 function have emerged 
in DA neuron development. These observations and interpretation need to be investigated 
further. 
 
4.6.1 The affinity model 
The affinity model has been previously described in C elegans where high affinity 
binding sites lead to the early expression of Foxa2 target genes and lower affinity binding 
sites lead to the delay in gene expression (Gaudet and Mango, 2002). Also, the affinity of 
the Foxa2 binding sites may play a role in the expression profile of cells of specific tissue 
depending on the expression levels of Foxa2 (Figure 4-3)(Kele et al., 2006). For example, 
in the liver it has been shown that it is more likely to find Foxa2 target genes with lower 
affinity binding sites where Foxa2 expression levels are high (Tuteja et al., 2008). From 
our study the expression of two genes TH and AADC seem to fit this model. TH and 
AADC are both required in late neuronal function for DA synthesis but their expression 
is initiated at two different time points. The early expression (E10.5) of AADC correlates 
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with the presence of a high affinity (according to sequence compatibility) Foxa2 binding 
site within its neuronal promoter. Moreover, the later expression (E11.5) of TH correlates 
with the presence of a low affinity Foxa2 binding site within its promoter region. Given 
the large number of targets genes identified in this study at different time points of 
midbrain DA neuron development it would be interesting to further validate the affinity 
model for the temporal regulation of genes by Foxa2. 
  
 
 
 
 
 
 
 
 
 
Figure 4-3: The affinity model suggests that Foxa2 regulation of transcription may 
depend on the DNA binding motif it identifies on regulatory regions, as well as on its 
concentration in the cell. Lower concentrations are required to induce genes with high 
affinity motifs compared to genes with low affinity motifs within their regulatory 
regions. (Modified from Mango, 2009) 
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4.6.2 Combinatorial control and feed-forward loops 
A key mechanism that may provide progression of development with stable 
commitment to the mDA neuronal fate is the combinatorial control of transcription by 
multiple factors interacting with Foxa2. Furthermore, Foxa2 involvement has been 
suggested in feed forward loops where Foxa2 induces a target gene and together they co-
induce target genes involved in regulating developmental progression (Ang, 2006; 
Mango, 2009). Notably, in our study we have identified Foxa2 binding events on possible 
regulatory regions of candidate target genes that are regulators of key events in midbrain 
DA development (Lmx1a, Lmx1b, Neurog2, Nr4a2, and Pitx3). We have previously 
suggest that Otx2 and Foxa2 together induce the expression of Lmx1a, and both induce 
and restrict the expression of Lmx1b, the key specification factors of DA neurons. Gain 
of function analysis of Lmx1a in chick and loss of function analysis of Foxa2 in mouse 
demonstrate the regulation of expression of the proneural gene Neurog2, which is 
required for differentiation of mDA neurons (Huangfu and Anderson, 2006; Kele et al., 
2006), The Foxa2 peak identified close to the Neurog2 locus and the possible (well 
conserved) Lmx1a DNA binding motif within this region suggests this regulation may be 
direct (Figure 4-4). As suggested previously, Foxa2 together with Neurog2 may be 
directly required to induce Nurr1 (Nr4a2) since a peak was identified within its promoter 
and an E box motif was observed. Finally Nurr1 and Foxa2 co-regulate the Pitx3 element 
identified and all three regulate the expression of TH the mature DA neuronal marker 
(Figure 4-6). This is a complex network of interaction that requires further investigation. 
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Figure 4-4: Occupancy of Neurog2 conserved genomic element by Foxa2. (A) Schematic 
diagram of genomic region occupied by Foxa2 down stream of the Neurog2 gene, from data 
obtained by Foxa2 ChIP-Seq experiments on E12.5 ventral midbrain tissue. Arrow indicate 
peak called by peak calling algorithm MACS. (B) Schematic diagram indicating the position of 
the predicted Foxa2 and Lmx1a DNA binding sites. 
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Figure 4-5: Occupancy of the Nurr1 (Nr4a2) promoter by Foxa2. (A) Schematic 
diagram of the genomic region occupied by Foxa2, from data obtained by Foxa2 
ChIP-Seq experiments on E12.5 ventral midbrain tissue. Arrow indicates peak 
called by peak calling algorithm MACS. (B) Schematic diagram of mouse 
Nurr1promotes indicates the presence of predicted Foxa2.  
 
 
 167 
 
 
 
 
 168 
 
 
 
 
 
 
 
 
 
 
 
 
All together, our work provides extensive information regarding possible Foxa2 
functions during the development of mDA neurons through the identification of Foxa2 
direct targts. This data suggests that Foxa2 is required at multiple points in the 
development of mDA neurons: specification, and differentiation.  Further analysis is 
required to confirm these results, but nonetheless; we provide insights on the diverse 
range of functions Foxa2 may performs for the proper development of mDA neurons. 
 
 
 
 
 
Figure 4-6: Combinatorial regulation of mDA specific genes through feed forward loops. 
(1) During specification, Foxa2 induces directly Lmx1b while Otx2 regulates its dorsal 
limit. (2) Foxa2 and Otx2 possibly regulate directly the expression of Lmx1a within the 
floor plate region. (3) Foxa2 in combination with Lmx1a may induce directly Neurog2 
(Ngn2) and promote differentiation. (4) Foxa2 together with Neurog2 may regulate Nurr1 
(Nr4a2) by binding to its promoter. (5) Foxa2 and possibly in combination with Lmx1a 
and Nurr1 positively regulate Pitx3. (6) Finally, Foxa2, Nurr1 and Pitx3 are required for 
the induction of TH by regulating directly it’s promoter. (This is a hypothetical series of 
events during the specification and differentiation of mDA neurons that requires further 
analysis and validation). 
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4.7 Appendix A 
 
 
 
 
 
 
 
 
 
Figure 4-7: Coronal sections through adult mouse midbrain. In situ hybridization 
analysis of genes identified from the in vivo ChIP-Seq assays. Black area 
indicates expression within the DA area. Look at atlas next.  (Modified from the 
Allen brain atlas) 
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Figure 4-8: Coronal sections through adult mouse midbrain. Anatomy atlas of the 
adult mouse midbrain. Black region indicates DA population area (SNc, and 
VTA). (Modified from the Allen brain atlas) 
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4.8 Appendix B 
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Figure 4-9: Gene symbol, names and MGI IDs of genes mentioned in the in vitro 
ChIP-Seq analysis. 
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Figure 4-10: Genomic regions identified from the in vitro data set and used in 
ChIP-qPCR validation analysis using chromatin from E12.5 dissected ventral 
midbrain.  
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4.9 Appendix C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-11: Gene symbol, names and MGI IDs of genes mentioned in the in vivo ChIP-Seq 
analysis. 
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Figure 4-12: Genomic regions used in ChIP-qPCR analisys using E12.5, and 
E14.5 chromatin from dissected ventral midbrain 
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4.10 Appendix D 
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Figure 4-13:Analysis of downstream targets of Shh signalling at E10.5 in 
the Foxa2 CKO (conditional knockout) mouse ventral mesencephalon. A-
J: Coronal sections of E10.5 wild type and Foxa2 CKO embryos. Analysis 
of the downstream targets of Shh signalling revealed that in E10.5 ventral 
mesencephalon the gene expression patterns of all the downstream 
targets of Shh signalling are shifted ventrally to meet the reduced Shh 
gene expression at the ventral midline. This suggests a possible role for 
Foxa2 in maintaining the expression boundary of these genes. 
Furthermore, Shh and Foxa1, known downstream targets of Foxa2, are 
reduced in these mutants. Scale bar represents 100µm. (Mavromatakis, 
2008) 
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